JP7476499B2 - Method for producing shikimic acid or its derivatives - Google Patents
Method for producing shikimic acid or its derivatives Download PDFInfo
- Publication number
- JP7476499B2 JP7476499B2 JP2019159036A JP2019159036A JP7476499B2 JP 7476499 B2 JP7476499 B2 JP 7476499B2 JP 2019159036 A JP2019159036 A JP 2019159036A JP 2019159036 A JP2019159036 A JP 2019159036A JP 7476499 B2 JP7476499 B2 JP 7476499B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- liquid
- derivative
- shikimic acid
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 title claims description 50
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 title claims description 50
- 238000004519 manufacturing process Methods 0.000 title claims description 38
- 239000007788 liquid Substances 0.000 claims description 95
- 238000000034 method Methods 0.000 claims description 88
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 79
- 239000002904 solvent Substances 0.000 claims description 63
- 239000002994 raw material Substances 0.000 claims description 53
- 238000001035 drying Methods 0.000 claims description 52
- 239000007787 solid Substances 0.000 claims description 47
- 239000000047 product Substances 0.000 claims description 42
- 238000011282 treatment Methods 0.000 claims description 37
- 239000000284 extract Substances 0.000 claims description 36
- 238000000605 extraction Methods 0.000 claims description 34
- 239000002253 acid Substances 0.000 claims description 17
- 238000001556 precipitation Methods 0.000 claims description 17
- 239000002028 Biomass Substances 0.000 claims description 15
- 238000001179 sorption measurement Methods 0.000 claims description 12
- 238000001291 vacuum drying Methods 0.000 claims description 11
- 239000002274 desiccant Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000007791 liquid phase Substances 0.000 claims description 8
- 230000020477 pH reduction Effects 0.000 claims description 8
- 239000002244 precipitate Substances 0.000 claims description 8
- 238000001226 reprecipitation Methods 0.000 claims description 7
- 238000001704 evaporation Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 5
- 238000010998 test method Methods 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 2
- 150000001923 cyclic compounds Chemical class 0.000 description 118
- 229920006395 saturated elastomer Polymers 0.000 description 26
- 239000000463 material Substances 0.000 description 20
- 238000010438 heat treatment Methods 0.000 description 19
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 125000004432 carbon atom Chemical group C* 0.000 description 18
- 238000002425 crystallisation Methods 0.000 description 18
- 230000008025 crystallization Effects 0.000 description 18
- 150000001875 compounds Chemical class 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- -1 iso-n-pentanol Chemical compound 0.000 description 11
- 238000012546 transfer Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 9
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 9
- 238000000926 separation method Methods 0.000 description 9
- 238000000956 solid--liquid extraction Methods 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 8
- 125000003118 aryl group Chemical group 0.000 description 8
- 150000001721 carbon Chemical group 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 8
- 239000012535 impurity Substances 0.000 description 8
- 238000001694 spray drying Methods 0.000 description 8
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 7
- 150000001555 benzenes Chemical class 0.000 description 7
- 238000009835 boiling Methods 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 238000004925 denaturation Methods 0.000 description 6
- 230000036425 denaturation Effects 0.000 description 6
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 5
- 125000003277 amino group Chemical group 0.000 description 5
- 125000004429 atom Chemical group 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 150000002430 hydrocarbons Chemical class 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- GLDQAMYCGOIJDV-UHFFFAOYSA-N 2,3-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1O GLDQAMYCGOIJDV-UHFFFAOYSA-N 0.000 description 4
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 4
- LBKFGYZQBSGRHY-UHFFFAOYSA-N 3-hydroxy-4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1O LBKFGYZQBSGRHY-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 4
- 125000003545 alkoxy group Chemical group 0.000 description 4
- 150000001491 aromatic compounds Chemical class 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- YOPYGGKAYWMQAB-UHFFFAOYSA-N diptoindonesin Natural products OCC1OC(C(O)C(O)C1O)c2c(O)cc(C=Cc3ccc(O)cc3)c4C(C(Oc24)c5ccc(O)cc5)c6cc(O)cc(O)c6 YOPYGGKAYWMQAB-UHFFFAOYSA-N 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 4
- 238000000622 liquid--liquid extraction Methods 0.000 description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000000935 solvent evaporation Methods 0.000 description 4
- 238000000638 solvent extraction Methods 0.000 description 4
- JMSVCTWVEWCHDZ-UHFFFAOYSA-N syringic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1O JMSVCTWVEWCHDZ-UHFFFAOYSA-N 0.000 description 4
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 4
- WTFXTQVDAKGDEY-UHFFFAOYSA-N (-)-chorismic acid Natural products OC1C=CC(C(O)=O)=CC1OC(=C)C(O)=O WTFXTQVDAKGDEY-UHFFFAOYSA-N 0.000 description 3
- IJFXRHURBJZNAO-UHFFFAOYSA-N 3-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1 IJFXRHURBJZNAO-UHFFFAOYSA-N 0.000 description 3
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- WTFXTQVDAKGDEY-HTQZYQBOSA-N Chorismic acid Natural products O[C@@H]1C=CC(C(O)=O)=C[C@H]1OC(=C)C(O)=O WTFXTQVDAKGDEY-HTQZYQBOSA-N 0.000 description 3
- RTIXKCRFFJGDFG-UHFFFAOYSA-N Chrysin Natural products C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical class OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- DZAUWHJDUNRCTF-UHFFFAOYSA-N dihydrocaffeic acid Natural products OC(=O)CCC1=CC=C(O)C(O)=C1 DZAUWHJDUNRCTF-UHFFFAOYSA-N 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- IWYDHOAUDWTVEP-UHFFFAOYSA-N mandelic acid Chemical compound OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- FPWMCUPFBRFMLH-UHFFFAOYSA-N prephenic acid Natural products OC1C=CC(CC(=O)C(O)=O)(C(O)=O)C=C1 FPWMCUPFBRFMLH-UHFFFAOYSA-N 0.000 description 3
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 3
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 3
- FQWLMRXWKZGLFI-YVYUXZJTSA-N (-)-trans-epsilon-viniferin Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC2=C1[C@@H](C=1C=C(O)C=C(O)C=1)[C@H](C=1C=CC(O)=CC=1)O2 FQWLMRXWKZGLFI-YVYUXZJTSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- BHLYRWXGMIUIHG-HNNXBMFYSA-N (S)-reticuline Chemical compound C1=C(O)C(OC)=CC=C1C[C@H]1C2=CC(O)=C(OC)C=C2CCN1C BHLYRWXGMIUIHG-HNNXBMFYSA-N 0.000 description 2
- GDVRUDXLQBVIKP-HQHREHCSSA-N 1-O-galloyl-beta-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(=O)C1=CC(O)=C(O)C(O)=C1 GDVRUDXLQBVIKP-HQHREHCSSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- KVZUCOGWKYOPID-UHFFFAOYSA-N 2,4,5-Trimethoxybenzoic acid Chemical compound COC1=CC(OC)=C(C(O)=O)C=C1OC KVZUCOGWKYOPID-UHFFFAOYSA-N 0.000 description 2
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 2
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- CFFZDZCDUFSOFZ-UHFFFAOYSA-N 3,4-Dihydroxy-phenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C(O)=C1 CFFZDZCDUFSOFZ-UHFFFAOYSA-N 0.000 description 2
- FBTSUTGMWBDAAC-UHFFFAOYSA-N 3,4-Dihydroxystyrene Chemical compound OC1=CC=C(C=C)C=C1O FBTSUTGMWBDAAC-UHFFFAOYSA-N 0.000 description 2
- LXCUAFVVTHZALS-UHFFFAOYSA-N 3-(3-methoxyphenyl)piperidine Chemical compound COC1=CC=CC(C2CNCCC2)=C1 LXCUAFVVTHZALS-UHFFFAOYSA-N 0.000 description 2
- WVMWZWGZRAXUBK-SYTVJDICSA-M 3-dehydroquinate Chemical compound O[C@@H]1C[C@](O)(C([O-])=O)CC(=O)[C@H]1O WVMWZWGZRAXUBK-SYTVJDICSA-M 0.000 description 2
- WVMWZWGZRAXUBK-UHFFFAOYSA-N 3-dehydroquinic acid Natural products OC1CC(O)(C(O)=O)CC(=O)C1O WVMWZWGZRAXUBK-UHFFFAOYSA-N 0.000 description 2
- SLWWJZMPHJJOPH-PHDIDXHHSA-N 3-dehydroshikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=CC(=O)[C@H]1O SLWWJZMPHJJOPH-PHDIDXHHSA-N 0.000 description 2
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 2
- VXIXUWQIVKSKSA-UHFFFAOYSA-N 4-hydroxycoumarin Chemical compound C1=CC=CC2=C1OC(=O)C=C2O VXIXUWQIVKSKSA-UHFFFAOYSA-N 0.000 description 2
- FUGYGGDSWSUORM-UHFFFAOYSA-N 4-hydroxystyrene Chemical compound OC1=CC=C(C=C)C=C1 FUGYGGDSWSUORM-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- BAVONGHXFVOKBV-UHFFFAOYSA-N Carveol Chemical compound CC(=C)C1CC=C(C)C(O)C1 BAVONGHXFVOKBV-UHFFFAOYSA-N 0.000 description 2
- SLWWJZMPHJJOPH-UHFFFAOYSA-N DHS Natural products OC1CC(C(O)=O)=CC(=O)C1O SLWWJZMPHJJOPH-UHFFFAOYSA-N 0.000 description 2
- XNEFHYFPRJBTJF-UHFFFAOYSA-N Dehydroshikimic acid Chemical compound OC1C=C(C(O)=O)CC(=O)C1O XNEFHYFPRJBTJF-UHFFFAOYSA-N 0.000 description 2
- ZFMSMUAANRJZFM-UHFFFAOYSA-N Estragole Chemical compound COC1=CC=C(CC=C)C=C1 ZFMSMUAANRJZFM-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- PHIHHTIYURVLDB-UHFFFAOYSA-N H-gnetine Natural products C1=CC(O)=CC=C1C=CC1=C(C(C(O2)C=3C=CC(O)=CC=3)C=3C=C(O)C=C(O)C=3)C2=CC2=C1C(C=1C=C(O)C=C(O)C=1)C(C=1C=CC(O)=CC=1)O2 PHIHHTIYURVLDB-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 150000001334 alicyclic compounds Chemical class 0.000 description 2
- 150000007824 aliphatic compounds Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- UJMDYLWCYJJYMO-UHFFFAOYSA-N benzene-1,2,3-tricarboxylic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1C(O)=O UJMDYLWCYJJYMO-UHFFFAOYSA-N 0.000 description 2
- QMKYBPDZANOJGF-UHFFFAOYSA-N benzene-1,3,5-tricarboxylic acid Chemical compound OC(=O)C1=CC(C(O)=O)=CC(C(O)=O)=C1 QMKYBPDZANOJGF-UHFFFAOYSA-N 0.000 description 2
- 235000004883 caffeic acid Nutrition 0.000 description 2
- 229940074360 caffeic acid Drugs 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 2
- JMFRWRFFLBVWSI-NSCUHMNNSA-N coniferol Chemical compound COC1=CC(\C=C\CO)=CC=C1O JMFRWRFFLBVWSI-NSCUHMNNSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- BOLQJTPHPSDZHR-UHFFFAOYSA-N dihydroferulic acid Chemical compound COC1=CC(CCC(O)=O)=CC=C1O BOLQJTPHPSDZHR-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 150000002391 heterocyclic compounds Chemical class 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- QNVRIHYSUZMSGM-UHFFFAOYSA-N hexan-2-ol Chemical compound CCCCC(C)O QNVRIHYSUZMSGM-UHFFFAOYSA-N 0.000 description 2
- ZHQLTKAVLJKSKR-UHFFFAOYSA-N homophthalic acid Chemical compound OC(=O)CC1=CC=CC=C1C(O)=O ZHQLTKAVLJKSKR-UHFFFAOYSA-N 0.000 description 2
- QRMZSPFSDQBLIX-UHFFFAOYSA-N homovanillic acid Chemical compound COC1=CC(CC(O)=O)=CC=C1O QRMZSPFSDQBLIX-UHFFFAOYSA-N 0.000 description 2
- WUAXWQRULBZETB-UHFFFAOYSA-N homoveratric acid Chemical compound COC1=CC=C(CC(O)=O)C=C1OC WUAXWQRULBZETB-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 description 2
- 229930013686 lignan Natural products 0.000 description 2
- 235000009408 lignans Nutrition 0.000 description 2
- 150000005692 lignans Chemical class 0.000 description 2
- KZMACGJDUUWFCH-UHFFFAOYSA-O malvidin Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KZMACGJDUUWFCH-UHFFFAOYSA-O 0.000 description 2
- YDSWCNNOKPMOTP-UHFFFAOYSA-N mellitic acid Chemical compound OC(=O)C1=C(C(O)=O)C(C(O)=O)=C(C(O)=O)C(C(O)=O)=C1C(O)=O YDSWCNNOKPMOTP-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical compound OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- NDTYTMIUWGWIMO-UHFFFAOYSA-N perillyl alcohol Chemical compound CC(=C)C1CCC(CO)=CC1 NDTYTMIUWGWIMO-UHFFFAOYSA-N 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 2
- VGEREEWJJVICBM-UHFFFAOYSA-N phloretin Chemical compound C1=CC(O)=CC=C1CCC(=O)C1=C(O)C=C(O)C=C1O VGEREEWJJVICBM-UHFFFAOYSA-N 0.000 description 2
- 125000003386 piperidinyl group Chemical group 0.000 description 2
- FPWMCUPFBRFMLH-HDKIZWTHSA-N prephenic acid Chemical compound O[C@H]1C=C[C@](CC(=O)C(O)=O)(C(O)=O)C=C1 FPWMCUPFBRFMLH-HDKIZWTHSA-N 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- CYIDZMCFTVVTJO-UHFFFAOYSA-N pyromellitic acid Chemical compound OC(=O)C1=CC(C(O)=O)=C(C(O)=O)C=C1C(O)=O CYIDZMCFTVVTJO-UHFFFAOYSA-N 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 230000004043 responsiveness Effects 0.000 description 2
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 150000003436 stilbenoids Chemical class 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- YIBXWXOYFGZLRU-UHFFFAOYSA-N syringic aldehyde Natural products CC12CCC(C3(CCC(=O)C(C)(C)C3CC=3)C)C=3C1(C)CCC2C1COC(C)(C)C(O)C(O)C1 YIBXWXOYFGZLRU-UHFFFAOYSA-N 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- YCVPRTHEGLPYPB-VOTSOKGWSA-N trans-pinosylvin Chemical compound OC1=CC(O)=CC(\C=C\C=2C=CC=CC=2)=C1 YCVPRTHEGLPYPB-VOTSOKGWSA-N 0.000 description 2
- ARCGXLSVLAOJQL-UHFFFAOYSA-N trimellitic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 ARCGXLSVLAOJQL-UHFFFAOYSA-N 0.000 description 2
- 229960004441 tyrosine Drugs 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 2
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- PSQYTAPXSHCGMF-BQYQJAHWSA-N β-ionone Chemical compound CC(=O)\C=C\C1=C(C)CCCC1(C)C PSQYTAPXSHCGMF-BQYQJAHWSA-N 0.000 description 2
- SFEOKXHPFMOVRM-UHFFFAOYSA-N (+)-(S)-gamma-ionone Natural products CC(=O)C=CC1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-UHFFFAOYSA-N 0.000 description 1
- KUTVNHOAKHJJFL-ZSIJVUTGSA-N (+)-alpha-viniferin Chemical compound C1=CC(O)=CC=C1[C@@H](O1)[C@H]2C(C=C(O)C=C3O[C@H]4C=5C=CC(O)=CC=5)=C3[C@H]4C(C=C(O)C=C3O[C@H]4C=5C=CC(O)=CC=5)=C3[C@H]4C3=C2C1=CC(O)=C3 KUTVNHOAKHJJFL-ZSIJVUTGSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- MHXCIKYXNYCMHY-AUSJPIAWSA-N (+)-lariciresinol Chemical compound C1=C(O)C(OC)=CC(C[C@@H]2[C@@H]([C@H](OC2)C=2C=C(OC)C(O)=CC=2)CO)=C1 MHXCIKYXNYCMHY-AUSJPIAWSA-N 0.000 description 1
- WTOYNNBCKUYIKC-JMSVASOKSA-N (+)-nootkatone Chemical compound C1C[C@@H](C(C)=C)C[C@@]2(C)[C@H](C)CC(=O)C=C21 WTOYNNBCKUYIKC-JMSVASOKSA-N 0.000 description 1
- RUPUUZZJJXCDHS-UHFFFAOYSA-N (+)-orientaline Natural products C1=C(O)C(OC)=CC(CC2C3=CC(O)=C(OC)C=C3CCN2C)=C1 RUPUUZZJJXCDHS-UHFFFAOYSA-N 0.000 description 1
- HGXBRUKMWQGOIE-AFHBHXEDSA-N (+)-pinoresinol Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C(OC)C(O)=CC=3)CO2)=C1 HGXBRUKMWQGOIE-AFHBHXEDSA-N 0.000 description 1
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- QEBNYNLSCGVZOH-NFAWXSAZSA-N (+)-valencene Chemical compound C1C[C@@H](C(C)=C)C[C@@]2(C)[C@H](C)CCC=C21 QEBNYNLSCGVZOH-NFAWXSAZSA-N 0.000 description 1
- NQWVSMVXKMHKTF-JKSUJKDBSA-N (-)-Arctigenin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O)=CC=2)C(=O)OC1 NQWVSMVXKMHKTF-JKSUJKDBSA-N 0.000 description 1
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- MATGKVZWFZHCLI-LSDHHAIUSA-N (-)-matairesinol Chemical compound C1=C(O)C(OC)=CC(C[C@@H]2[C@H](C(=O)OC2)CC=2C=C(OC)C(O)=CC=2)=C1 MATGKVZWFZHCLI-LSDHHAIUSA-N 0.000 description 1
- GEWDNTWNSAZUDX-WQMVXFAESA-N (-)-methyl jasmonate Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-WQMVXFAESA-N 0.000 description 1
- PUETUDUXMCLALY-HOTGVXAUSA-N (-)-secoisolariciresinol Chemical compound C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 PUETUDUXMCLALY-HOTGVXAUSA-N 0.000 description 1
- BAVONGHXFVOKBV-ZJUUUORDSA-N (-)-trans-carveol Natural products CC(=C)[C@@H]1CC=C(C)[C@@H](O)C1 BAVONGHXFVOKBV-ZJUUUORDSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- PAFLSMZLRSPALU-MRVPVSSYSA-N (2R)-3-(3,4-dihydroxyphenyl)lactic acid Chemical compound OC(=O)[C@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-MRVPVSSYSA-N 0.000 description 1
- 239000001890 (2R)-8,8,8a-trimethyl-2-prop-1-en-2-yl-1,2,3,4,6,7-hexahydronaphthalene Substances 0.000 description 1
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- NWCHELUCVWSRRS-SECBINFHSA-N (2r)-2-hydroxy-2-phenylpropanoic acid Chemical compound OC(=O)[C@@](O)(C)C1=CC=CC=C1 NWCHELUCVWSRRS-SECBINFHSA-N 0.000 description 1
- SDOFMBGMRVAJNF-KVTDHHQDSA-N (2r,3r,4r,5r)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-KVTDHHQDSA-N 0.000 description 1
- JEQRSDJVWOFRBQ-ILLDPMRGSA-N (2s,3r)-3-hydroxy-2-[[(2s,3s)-3-hydroxy-2-methyl-2-(4-methylpent-3-enyl)-3,4-dihydrochromene-6-carbonyl]amino]butanoic acid Chemical compound O1[C@@](C)(CCC=C(C)C)[C@@H](O)CC2=CC(C(=O)N[C@@H]([C@H](O)C)C(O)=O)=CC=C21 JEQRSDJVWOFRBQ-ILLDPMRGSA-N 0.000 description 1
- 229940098795 (3z)- 3-hexenyl acetate Drugs 0.000 description 1
- QBLFZIBJXUQVRF-UHFFFAOYSA-N (4-bromophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Br)C=C1 QBLFZIBJXUQVRF-UHFFFAOYSA-N 0.000 description 1
- OQWKEEOHDMUXEO-UHFFFAOYSA-N (6)-shogaol Natural products CCCCCC=CC(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-UHFFFAOYSA-N 0.000 description 1
- ZWTDXYUDJYDHJR-UHFFFAOYSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O ZWTDXYUDJYDHJR-UHFFFAOYSA-N 0.000 description 1
- KUWZXOMQXYWKBS-UHFFFAOYSA-N (E)-2-(5-hydroxy-3-methoxyphenyl)-1-(4'-hydroxyphenyl)ethylene Natural products COC1=CC(O)=CC(C=CC=2C=CC(O)=CC=2)=C1 KUWZXOMQXYWKBS-UHFFFAOYSA-N 0.000 description 1
- PERPNFLGJXUDDW-UHFFFAOYSA-N (E)-3'-beta-D-Glucopyranosyloxy-3,4,5'-trihydroxystilbene Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 PERPNFLGJXUDDW-UHFFFAOYSA-N 0.000 description 1
- ZCKDCRKBURQZPT-OWOJBTEDSA-N (E)-caffeyl alcohol Chemical compound OC\C=C\C1=CC=C(O)C(O)=C1 ZCKDCRKBURQZPT-OWOJBTEDSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 1
- HSTZMXCBWJGKHG-UHFFFAOYSA-N (E)-piceid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(C=CC=2C=CC(O)=CC=2)=C1 HSTZMXCBWJGKHG-UHFFFAOYSA-N 0.000 description 1
- RUMOYJJNUMEFDD-SNVBAGLBSA-N (R)-(+)-Perillaldehyde Natural products CC(=C)[C@H]1CCC(C=O)=CC1 RUMOYJJNUMEFDD-SNVBAGLBSA-N 0.000 description 1
- FTVWIRXFELQLPI-CYBMUJFWSA-N (R)-naringenin Chemical compound C1=CC(O)=CC=C1[C@@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-CYBMUJFWSA-N 0.000 description 1
- UFLHIIWVXFIJGU-ARJAWSKDSA-N (Z)-hex-3-en-1-ol Chemical compound CC\C=C/CCO UFLHIIWVXFIJGU-ARJAWSKDSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- OYWRDHBGMCXGFY-UHFFFAOYSA-N 1,2,3-triazinane Chemical group C1CNNNC1 OYWRDHBGMCXGFY-UHFFFAOYSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 1
- VBSTXRUAXCTZBQ-UHFFFAOYSA-N 1-hexyl-4-phenylpiperazine Chemical compound C1CN(CCCCCC)CCN1C1=CC=CC=C1 VBSTXRUAXCTZBQ-UHFFFAOYSA-N 0.000 description 1
- BRRSNXCXLSVPFC-UHFFFAOYSA-N 2,3,4-Trihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1O BRRSNXCXLSVPFC-UHFFFAOYSA-N 0.000 description 1
- JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical group C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 description 1
- 229940082044 2,3-dihydroxybenzoic acid Drugs 0.000 description 1
- HGEFWFBFQKWVMY-DUXPYHPUSA-N 2,4-dihydroxy-trans cinnamic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C=C1O HGEFWFBFQKWVMY-DUXPYHPUSA-N 0.000 description 1
- VVEMXQMSJUUTFO-UHFFFAOYSA-N 2,6-dihydroxybenzoic acid Chemical compound OC(=O)C1=C(O)C=CC=C1O.OC(=O)C1=C(O)C=CC=C1O VVEMXQMSJUUTFO-UHFFFAOYSA-N 0.000 description 1
- TZPBMNKOLMSJPF-BZNQNGANSA-N 2-(beta-D-glucopyranosyloxy)benzoic acid Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1C(O)=O TZPBMNKOLMSJPF-BZNQNGANSA-N 0.000 description 1
- QNVRIHYSUZMSGM-LURJTMIESA-N 2-Hexanol Natural products CCCC[C@H](C)O QNVRIHYSUZMSGM-LURJTMIESA-N 0.000 description 1
- QYCBZFRDGXIZIP-UHFFFAOYSA-N 2-hydroxy-2-phenylbutanoic acid Chemical compound CCC(O)(C(O)=O)C1=CC=CC=C1 QYCBZFRDGXIZIP-UHFFFAOYSA-N 0.000 description 1
- VHBSECWYEFJRNV-UHFFFAOYSA-N 2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1O.OC(=O)C1=CC=CC=C1O VHBSECWYEFJRNV-UHFFFAOYSA-N 0.000 description 1
- YOMSJEATGXXYPX-UHFFFAOYSA-N 2-methoxy-4-vinylphenol Chemical compound COC1=CC(C=C)=CC=C1O YOMSJEATGXXYPX-UHFFFAOYSA-N 0.000 description 1
- LFLOMAIEONDOLV-UHFFFAOYSA-N 2-oxalobenzoic acid Chemical compound OC(=O)C(=O)C1=CC=CC=C1C(O)=O LFLOMAIEONDOLV-UHFFFAOYSA-N 0.000 description 1
- 239000001903 2-oxo-3-phenylpropanoic acid Substances 0.000 description 1
- ONPJWQSDZCGSQM-UHFFFAOYSA-N 2-phenylprop-2-enoic acid Chemical compound OC(=O)C(=C)C1=CC=CC=C1 ONPJWQSDZCGSQM-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- VHMICKWLTGFITH-UHFFFAOYSA-N 2H-isoindole Chemical compound C1=CC=CC2=CNC=C21 VHMICKWLTGFITH-UHFFFAOYSA-N 0.000 description 1
- AGIJRRREJXSQJR-UHFFFAOYSA-N 2h-thiazine Chemical group N1SC=CC=C1 AGIJRRREJXSQJR-UHFFFAOYSA-N 0.000 description 1
- UMGCIIXWEFTPOC-UHFFFAOYSA-N 3,4,3',5'-Tetrahydroxystilbene-3-glucoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(C=CC=2C=C(O)C=C(O)C=2)=CC=C1O UMGCIIXWEFTPOC-UHFFFAOYSA-N 0.000 description 1
- DAUAQNGYDSHRET-UHFFFAOYSA-N 3,4-dimethoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1OC DAUAQNGYDSHRET-UHFFFAOYSA-N 0.000 description 1
- UYEMGAFJOZZIFP-UHFFFAOYSA-N 3,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC(O)=C1 UYEMGAFJOZZIFP-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- JVGVDSSUAVXRDY-UHFFFAOYSA-N 3-(4-hydroxyphenyl)lactic acid Chemical compound OC(=O)C(O)CC1=CC=C(O)C=C1 JVGVDSSUAVXRDY-UHFFFAOYSA-N 0.000 description 1
- QNUWEXSGZVBMDV-UHFFFAOYSA-N 3-(carboxymethyl)benzoic acid Chemical compound OC(=O)CC1=CC=CC(C(O)=O)=C1 QNUWEXSGZVBMDV-UHFFFAOYSA-N 0.000 description 1
- KUWZXOMQXYWKBS-NSCUHMNNSA-N 3-methoxy-4',5-dihydroxy-trans-stilbene Chemical compound COC1=CC(O)=CC(\C=C\C=2C=CC(O)=CC=2)=C1 KUWZXOMQXYWKBS-NSCUHMNNSA-N 0.000 description 1
- WVPYGTHKWYSUNM-UHFFFAOYSA-N 3-oxalobenzoic acid Chemical compound OC(=O)C(=O)C1=CC=CC(C(O)=O)=C1 WVPYGTHKWYSUNM-UHFFFAOYSA-N 0.000 description 1
- PYIZAVSVITVBMS-UHFFFAOYSA-N 3-phenyl-3,4-dihydrochromene-2,2-diol Chemical class OC1(O)OC2=CC=CC=C2CC1C1=CC=CC=C1 PYIZAVSVITVBMS-UHFFFAOYSA-N 0.000 description 1
- VOXXWSYKYCBWHO-UHFFFAOYSA-M 3-phenyllactate Chemical compound [O-]C(=O)C(O)CC1=CC=CC=C1 VOXXWSYKYCBWHO-UHFFFAOYSA-M 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- PUQSUZTXKPLAPR-KSSYENDESA-N 4-(beta-D-Glucopyranosyloxy) benzyl alcohol Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-KSSYENDESA-N 0.000 description 1
- ALYNCZNDIQEVRV-PZFLKRBQSA-N 4-amino-3,5-ditritiobenzoic acid Chemical compound [3H]c1cc(cc([3H])c1N)C(O)=O ALYNCZNDIQEVRV-PZFLKRBQSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- IHVRWFJGOIWMGC-NSCUHMNNSA-N 4-methoxyresveratrol Chemical compound C1=CC(OC)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 IHVRWFJGOIWMGC-NSCUHMNNSA-N 0.000 description 1
- OBKXEAXTFZPCHS-UHFFFAOYSA-N 4-phenylbutyric acid Chemical compound OC(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-N 0.000 description 1
- SGNZYJXNUURYCH-UHFFFAOYSA-N 5,6-dihydroxyindole Chemical group C1=C(O)C(O)=CC2=C1NC=C2 SGNZYJXNUURYCH-UHFFFAOYSA-N 0.000 description 1
- NYCXYKOXLNBYID-UHFFFAOYSA-N 5,7-Dihydroxychromone Natural products O1C=CC(=O)C=2C1=CC(O)=CC=2O NYCXYKOXLNBYID-UHFFFAOYSA-N 0.000 description 1
- PHIHHTIYURVLDB-JPZOQBBBSA-N 5-[(2s,3s,5s,6s)-3-(3,5-dihydroxyphenyl)-2,6-bis(4-hydroxyphenyl)-4-[(e)-2-(4-hydroxyphenyl)ethenyl]-2,3,5,6-tetrahydrofuro[3,2-f][1]benzofuran-5-yl]benzene-1,3-diol Chemical compound C1=CC(O)=CC=C1\C=C\C1=C([C@@H]([C@H](O2)C=3C=CC(O)=CC=3)C=3C=C(O)C=C(O)C=3)C2=CC2=C1[C@H](C=1C=C(O)C=C(O)C=1)[C@@H](C=1C=CC(O)=CC=1)O2 PHIHHTIYURVLDB-JPZOQBBBSA-N 0.000 description 1
- KMRMUZKLFIEVAO-UHFFFAOYSA-N 7,7-dimethylbicyclo[3.1.1]hept-3-ene-4-carbaldehyde Chemical compound C1C2C(C)(C)C1CC=C2C=O KMRMUZKLFIEVAO-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- PHIHHTIYURVLDB-SIXZTWGTSA-N Ampelopsin E Natural products C1=CC(O)=CC=C1\C=C\C1=C([C@H]([C@H](O2)C=3C=CC(O)=CC=3)C=3C=C(O)C=C(O)C=3)C2=CC2=C1[C@@H](C=1C=C(O)C=C(O)C=1)[C@H](C=1C=CC(O)=CC=1)O2 PHIHHTIYURVLDB-SIXZTWGTSA-N 0.000 description 1
- YYGRXNOXOVZIKE-UHFFFAOYSA-N Arctigenin Natural products COC1CCC(CC2COC(=O)C2CC3CCC(O)C(C3)OC)CC1OC YYGRXNOXOVZIKE-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- MIEILDYWGANZNH-UHFFFAOYSA-N Arogenic acid Natural products OC(=O)C(N)CC1(C(O)=O)C=CC(O)C=C1 MIEILDYWGANZNH-UHFFFAOYSA-N 0.000 description 1
- PERPNFLGJXUDDW-YHDCXSKOSA-N Astringin Natural products OC[C@@H]1O[C@H](Oc2cc(O)cc(C=Cc3ccc(O)c(O)c3)c2)[C@H](O)[C@@H](O)[C@@H]1O PERPNFLGJXUDDW-YHDCXSKOSA-N 0.000 description 1
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- NTPAXPJSBGILOW-ZIKNSQGESA-N C(\C=C\C1=CC=C(C=C1)O)(=O)O.C(C=CC1=CC=CC=C1)(=O)O Chemical compound C(\C=C\C1=CC=C(C=C1)O)(=O)O.C(C=CC1=CC=CC=C1)(=O)O NTPAXPJSBGILOW-ZIKNSQGESA-N 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- HDOMLWFFJSLFBI-UHFFFAOYSA-N Eriocitrin Natural products CC1OC(OCC2OC(Oc3cc(O)c4C(=O)CC(Oc4c3)c5ccc(OC6OC(COC7OC(C)C(O)C(O)C7O)C(O)C(O)C6O)c(O)c5)C(O)C(O)C2O)C(O)C(O)C1O HDOMLWFFJSLFBI-UHFFFAOYSA-N 0.000 description 1
- OMQADRGFMLGFJF-MNPJBKLOSA-N Eriodictioside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=C(O)C(O)=CC=2)O1 OMQADRGFMLGFJF-MNPJBKLOSA-N 0.000 description 1
- KBEBGUQPQBELIU-CMDGGOBGSA-N Ethyl cinnamate Chemical compound CCOC(=O)\C=C\C1=CC=CC=C1 KBEBGUQPQBELIU-CMDGGOBGSA-N 0.000 description 1
- PUQSUZTXKPLAPR-UJPOAAIJSA-N Gastrodin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(CO)C=C1 PUQSUZTXKPLAPR-UJPOAAIJSA-N 0.000 description 1
- 229920000296 Glucogallin Polymers 0.000 description 1
- OIFFJDGSLVHPCW-UHFFFAOYSA-N Guayarol Natural products COc1ccc(CC2C(Cc3ccc(O)c(O)c3)COC2=O)cc1OC OIFFJDGSLVHPCW-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- YNOCUODOFOEIFZ-UHFFFAOYSA-N Hydroxymatairesinol Natural products C1=C(O)C(OC)=CC=C1CC1C(=O)OCC1C(O)C1=CC=C(OC)C(O)=C1 YNOCUODOFOEIFZ-UHFFFAOYSA-N 0.000 description 1
- ZHLWCBHWYUISFY-UHFFFAOYSA-N Hydroxyphenylpyruvic acid Chemical compound OC(=O)C(=O)C(O)C1=CC=CC=C1 ZHLWCBHWYUISFY-UHFFFAOYSA-N 0.000 description 1
- BJIOGJUNALELMI-ONEGZZNKSA-N Isoeugenol Natural products COC1=CC(\C=C\C)=CC=C1O BJIOGJUNALELMI-ONEGZZNKSA-N 0.000 description 1
- QURCVMIEKCOAJU-HWKANZROSA-N Isoferulic acid Natural products COC1=CC=C(\C=C\C(O)=O)C=C1O QURCVMIEKCOAJU-HWKANZROSA-N 0.000 description 1
- NQWVSMVXKMHKTF-UHFFFAOYSA-N L-Arctigenin Natural products C1=C(OC)C(OC)=CC=C1CC1C(CC=2C=C(OC)C(O)=CC=2)C(=O)OC1 NQWVSMVXKMHKTF-UHFFFAOYSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- MIEILDYWGANZNH-DSQUFTABSA-N L-arogenic acid Chemical compound OC(=O)[C@@H](N)CC1(C(O)=O)C=CC(O)C=C1 MIEILDYWGANZNH-DSQUFTABSA-N 0.000 description 1
- DBLDQZASZZMNSL-QMMMGPOBSA-N L-tyrosinol Natural products OC[C@@H](N)CC1=CC=C(O)C=C1 DBLDQZASZZMNSL-QMMMGPOBSA-N 0.000 description 1
- YVRYZXAHRGGELT-UHFFFAOYSA-N Lariciresinol Natural products C1=C2OCOC2=CC(C2C(C)C3(OC)C=C(CC=C)C(=O)CC3(O2)OC)=C1 YVRYZXAHRGGELT-UHFFFAOYSA-N 0.000 description 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
- MZSGWZGPESCJAN-MOBFUUNNSA-N Melitric acid A Natural products O([C@@H](C(=O)O)Cc1cc(O)c(O)cc1)C(=O)/C=C/c1cc(O)c(O/C(/C(=O)O)=C/c2cc(O)c(O)cc2)cc1 MZSGWZGPESCJAN-MOBFUUNNSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
- TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Natural products OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 1
- KMRMUZKLFIEVAO-RKDXNWHRSA-N Myrtenal Natural products C1[C@H]2C(C)(C)[C@@H]1CC=C2C=O KMRMUZKLFIEVAO-RKDXNWHRSA-N 0.000 description 1
- YQHMWTPYORBCMF-UHFFFAOYSA-N Naringenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1O YQHMWTPYORBCMF-UHFFFAOYSA-N 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- RINSJDWDXSWUOK-UHFFFAOYSA-N OC(=O)C1=CC=C(O)C(O)=C1.OC(=O)C1=CC=C(O)C(O)=C1 Chemical compound OC(=O)C1=CC=C(O)C(O)=C1.OC(=O)C1=CC=C(O)C(O)=C1 RINSJDWDXSWUOK-UHFFFAOYSA-N 0.000 description 1
- QKTAFNAZTCSZGF-UHFFFAOYSA-N OC(=O)C1=CC=C(O)C=C1O.OC(=O)C1=CC=C(O)C=C1O Chemical compound OC(=O)C1=CC=C(O)C=C1O.OC(=O)C1=CC=C(O)C=C1O QKTAFNAZTCSZGF-UHFFFAOYSA-N 0.000 description 1
- IOUVKUPGCMBWBT-DARKYYSBSA-N Phloridzin Natural products O[C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-DARKYYSBSA-N 0.000 description 1
- IIXHQGSINFQLRR-UHFFFAOYSA-N Piceatannol Natural products Oc1ccc(C=Cc2c(O)c(O)c3CCCCc3c2O)cc1O IIXHQGSINFQLRR-UHFFFAOYSA-N 0.000 description 1
- HSTZMXCBWJGKHG-CENDIDJXSA-N Piceid Natural products OC[C@@H]1O[C@@H](Oc2cc(O)cc(C=Cc3ccc(O)cc3)c2)[C@H](O)[C@H](O)[C@H]1O HSTZMXCBWJGKHG-CENDIDJXSA-N 0.000 description 1
- FGUBFGWYEYFGRK-HNNXBMFYSA-N Pinocembrin Natural products Cc1cc(C)c2C(=O)C[C@H](Oc2c1)c3ccccc3 FGUBFGWYEYFGRK-HNNXBMFYSA-N 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 description 1
- PAFLSMZLRSPALU-UHFFFAOYSA-N Salvianic acid A Natural products OC(=O)C(O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- XJTXBUKLGQCZHC-UHFFFAOYSA-N Steganacin Natural products C1=C2C=3C(OC)=C(OC)C(OC)=CC=3CC3C(=O)OCC3C(OC(C)=O)C2=CC2=C1OCO2 XJTXBUKLGQCZHC-UHFFFAOYSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical group C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- DPOPAJRDYZGTIR-UHFFFAOYSA-N Tetrazine Chemical group C1=CN=NN=N1 DPOPAJRDYZGTIR-UHFFFAOYSA-N 0.000 description 1
- YPWFISCTZQNZAU-UHFFFAOYSA-N Thiane Chemical group C1CCSCC1 YPWFISCTZQNZAU-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- JACRWUWPXAESPB-QMMMGPOBSA-N Tropic acid Natural products OC[C@H](C(O)=O)C1=CC=CC=C1 JACRWUWPXAESPB-QMMMGPOBSA-N 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- CGQCWMIAEPEHNQ-UHFFFAOYSA-N Vanillylmandelic acid Chemical compound COC1=CC(C(O)C(O)=O)=CC=C1O CGQCWMIAEPEHNQ-UHFFFAOYSA-N 0.000 description 1
- GPVDHNVGGIAOQT-UHFFFAOYSA-N Veratric acid Natural products COC1=CC=C(C(O)=O)C(OC)=C1 GPVDHNVGGIAOQT-UHFFFAOYSA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- OQWKEEOHDMUXEO-BQYQJAHWSA-N [6]-Shogaol Chemical compound CCCCC\C=C\C(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-BQYQJAHWSA-N 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- 239000012445 acidic reagent Substances 0.000 description 1
- QNHQEUFMIKRNTB-UHFFFAOYSA-N aesculetin Natural products C1CC(=O)OC2=C1C=C(O)C(O)=C2 QNHQEUFMIKRNTB-UHFFFAOYSA-N 0.000 description 1
- GUAFOGOEJLSQBT-UHFFFAOYSA-N aesculetin dimethyl ether Natural products C1=CC(=O)OC2=C1C=C(OC)C(OC)=C2 GUAFOGOEJLSQBT-UHFFFAOYSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- NESNOMLNDJUFBJ-UHFFFAOYSA-N alpha-Viniferin Natural products Oc1ccc(cc1)C2Oc3cc(O)cc4C5C(Oc6cc(O)cc(C7C(Oc8cc(O)cc(C2c34)c78)c9cccc(O)c9)c56)c%10cccc(O)c%10 NESNOMLNDJUFBJ-UHFFFAOYSA-N 0.000 description 1
- DEDGUGJNLNLJSR-UHFFFAOYSA-N alpha-hydroxycinnamic acid Natural products OC(=O)C(O)=CC1=CC=CC=C1 DEDGUGJNLNLJSR-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- LHUHHURKGTUZHU-UHFFFAOYSA-N ampelopsin A Natural products C12=C(O)C=C(O)C=C2C(C=23)C(C=4C=CC(O)=CC=4)OC3=CC(O)=CC=2C(O)C1C1=CC=C(O)C=C1 LHUHHURKGTUZHU-UHFFFAOYSA-N 0.000 description 1
- LHUHHURKGTUZHU-QWMXJGQVSA-N ampelopsin a Chemical compound C1([C@@H]2[C@H](C=3C=C(O)C=C4O[C@@H]([C@H](C=34)C3=CC(O)=CC(O)=C32)C=2C=CC(O)=CC=2)O)=CC=C(O)C=C1 LHUHHURKGTUZHU-QWMXJGQVSA-N 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- NWCHELUCVWSRRS-UHFFFAOYSA-N atrolactic acid Chemical compound OC(=O)C(O)(C)C1=CC=CC=C1 NWCHELUCVWSRRS-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 229930015036 aurone Natural products 0.000 description 1
- 150000001530 aurones Chemical class 0.000 description 1
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 1
- 229940015301 baicalein Drugs 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- GCAIEATUVJFSMC-UHFFFAOYSA-N benzene-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1C(O)=O GCAIEATUVJFSMC-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- GDVRUDXLQBVIKP-UHFFFAOYSA-N beta-D-glucogallin Natural products OC1C(O)C(O)C(CO)OC1OC(=O)C1=CC(O)=C(O)C(O)=C1 GDVRUDXLQBVIKP-UHFFFAOYSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 229930007646 carveol Natural products 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 150000001789 chalcones Chemical class 0.000 description 1
- PXUKGIXMZKRNMI-VCEXAHOOSA-N chembl1939277 Chemical compound C1=CC(O)=CC=C1[C@H]1[C@H](C=2C=C(O)C=C(O)C=2)C2=C([C@H]3[C@@H](C4=C(O)C=C5O[C@@H]([C@H]6C7=CC(O)=CC(O)=C7[C@H](C=7C=CC(O)=CC=7)[C@H]3C4=C65)C=3C=CC(O)=CC=3)C=3C=CC(O)=CC=3)C=C(O)C=C2O1 PXUKGIXMZKRNMI-VCEXAHOOSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000015838 chrysin Nutrition 0.000 description 1
- 229940043370 chrysin Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- KBEBGUQPQBELIU-UHFFFAOYSA-N cinnamic acid ethyl ester Natural products CCOC(=O)C=CC1=CC=CC=C1 KBEBGUQPQBELIU-UHFFFAOYSA-N 0.000 description 1
- CCRCUPLGCSFEDV-UHFFFAOYSA-N cinnamic acid methyl ester Natural products COC(=O)C=CC1=CC=CC=C1 CCRCUPLGCSFEDV-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- WJSDHUCWMSHDCR-VMPITWQZSA-N cinnamyl acetate Natural products CC(=O)OC\C=C\C1=CC=CC=C1 WJSDHUCWMSHDCR-VMPITWQZSA-N 0.000 description 1
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
- FQWLMRXWKZGLFI-UHFFFAOYSA-N cis epsilon-viniferine Natural products C1=CC(O)=CC=C1C=CC1=CC(O)=CC2=C1C(C=1C=C(O)C=C(O)C=1)C(C=1C=CC(O)=CC=1)O2 FQWLMRXWKZGLFI-UHFFFAOYSA-N 0.000 description 1
- NPFVOOAXDOBMCE-PLNGDYQASA-N cis-3-Hexenyl acetate Natural products CC\C=C/CCOC(C)=O NPFVOOAXDOBMCE-PLNGDYQASA-N 0.000 description 1
- RRGOKSYVAZDNKR-ARJAWSKDSA-M cis-3-hexenylacetate Chemical compound CC\C=C/CCCC([O-])=O RRGOKSYVAZDNKR-ARJAWSKDSA-M 0.000 description 1
- BJIOGJUNALELMI-ARJAWSKDSA-N cis-isoeugenol Chemical compound COC1=CC(\C=C/C)=CC=C1O BJIOGJUNALELMI-ARJAWSKDSA-N 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 229940119526 coniferyl alcohol Drugs 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229930182483 coumarin glycoside Natural products 0.000 description 1
- 150000008140 coumarin glycosides Chemical class 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- MGNZXYYWBUKAII-UHFFFAOYSA-N cyclohexa-1,3-diene Chemical group C1CC=CC=C1 MGNZXYYWBUKAII-UHFFFAOYSA-N 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- ZVIJTQFTLXXGJA-UHFFFAOYSA-N dihydroisoferulic acid Chemical compound COC1=CC=C(CCC(O)=O)C=C1O ZVIJTQFTLXXGJA-UHFFFAOYSA-N 0.000 description 1
- KQILIWXGGKGKNX-UHFFFAOYSA-N dihydromyricetin Natural products OC1C(=C(Oc2cc(O)cc(O)c12)c3cc(O)c(O)c(O)c3)O KQILIWXGGKGKNX-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- WTOYNNBCKUYIKC-UHFFFAOYSA-N dl-nootkatone Natural products C1CC(C(C)=C)CC2(C)C(C)CC(=O)C=C21 WTOYNNBCKUYIKC-UHFFFAOYSA-N 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 229920006351 engineering plastic Polymers 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- YJGVMLPVUAXIQN-UHFFFAOYSA-N epipodophyllotoxin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YJGVMLPVUAXIQN-UHFFFAOYSA-N 0.000 description 1
- SXRAUGAFMDOHKN-UHFFFAOYSA-N epsilon-viniferin Natural products CC1(Oc2cc(O)cc(C=Cc3ccc(O)cc3)c2C1(C)c4cc(O)cc(O)c4)c5ccc(O)cc5 SXRAUGAFMDOHKN-UHFFFAOYSA-N 0.000 description 1
- SBHXYTNGIZCORC-ZDUSSCGKSA-N eriodictyol Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)O)=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-ZDUSSCGKSA-N 0.000 description 1
- TUJPOVKMHCLXEL-UHFFFAOYSA-N eriodictyol Natural products C1C(=O)C2=CC(O)=CC(O)=C2OC1C1=CC=C(O)C(O)=C1 TUJPOVKMHCLXEL-UHFFFAOYSA-N 0.000 description 1
- 235000011797 eriodictyol Nutrition 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- SBHXYTNGIZCORC-UHFFFAOYSA-N eriodyctiol Natural products O1C2=CC(O)=CC(O)=C2C(=O)CC1C1=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-UHFFFAOYSA-N 0.000 description 1
- ILEDWLMCKZNDJK-UHFFFAOYSA-N esculetin Chemical compound C1=CC(=O)OC2=C1C=C(O)C(O)=C2 ILEDWLMCKZNDJK-UHFFFAOYSA-N 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 125000002573 ethenylidene group Chemical group [*]=C=C([H])[H] 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 229930003487 europinidin Natural products 0.000 description 1
- XJXMPIWHBIOJSH-UHFFFAOYSA-O europinidin Chemical compound OC1=C(O)C(OC)=CC(C=2C(=CC=3C(OC)=CC(O)=CC=3[O+]=2)O)=C1 XJXMPIWHBIOJSH-UHFFFAOYSA-O 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical class C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 150000002208 flavanones Chemical class 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229930193974 gastrodin Natural products 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- SXFWLVJIOLHNNS-UHFFFAOYSA-N gnetin H Natural products CC1(Oc2cc3OC(C)(c4ccc(O)cc4)C(C)(c5cc(O)cc(O)c5)c3c(C=Cc6ccc(O)cc6)c2C1(C)c7cc(O)cc(O)c7)c8ccc(O)cc8 SXFWLVJIOLHNNS-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- PUQSUZTXKPLAPR-NZEXEKPDSA-N helicidol Natural products O([C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-NZEXEKPDSA-N 0.000 description 1
- PXUKGIXMZKRNMI-UHFFFAOYSA-N hemsleyanol D Natural products C1=CC(O)=CC=C1C1C(C=2C=C(O)C=C(O)C=2)C2=C(C3C(C4=C(O)C=C5OC(C6C7=CC(O)=CC(O)=C7C(C=7C=CC(O)=CC=7)C3C4=C65)C=3C=CC(O)=CC=3)C=3C=CC(O)=CC=3)C=C(O)C=C2O1 PXUKGIXMZKRNMI-UHFFFAOYSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- UFLHIIWVXFIJGU-UHFFFAOYSA-N hex-3-en-1-ol Natural products CCC=CCCO UFLHIIWVXFIJGU-UHFFFAOYSA-N 0.000 description 1
- YQQUILZPDYJDQJ-KGDQSQJYSA-N hopeaphenol Chemical compound C1=CC(O)=CC=C1[C@H](O1)[C@@H]2C3=CC(O)=CC(O)=C3[C@@H](C=3C=CC(O)=CC=3)[C@H]([C@@H]3C=4C=C(O)C=C5O[C@H]([C@@H](C=45)C4=CC(O)=CC(O)=C4[C@H]3C=3C=CC(O)=CC=3)C=3C=CC(O)=CC=3)C3=C2C1=CC(O)=C3 YQQUILZPDYJDQJ-KGDQSQJYSA-N 0.000 description 1
- YQQUILZPDYJDQJ-PLGGFYDZSA-N hopeaphenol Natural products Oc1ccc(cc1)[C@@H]2Oc3cc(O)cc4[C@H]([C@@H]5[C@@H](c6ccc(O)cc6)c7c(O)cc(O)cc7[C@@H]8[C@H](Oc9cc(O)cc5c89)c%10ccc(O)cc%10)[C@@H](c%11ccc(O)cc%11)c%12c(O)cc(O)cc%12[C@@H]2c34 YQQUILZPDYJDQJ-PLGGFYDZSA-N 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- UKHWOLNMBQSCLJ-BIENJYKASA-N hydroxymatairesinol Chemical compound C1=C(O)C(OC)=CC(C[C@H]2C(OC[C@@H]2[C@H](O)C=2C=C(OC)C(O)=CC=2)=O)=C1 UKHWOLNMBQSCLJ-BIENJYKASA-N 0.000 description 1
- GFAZHVHNLUBROE-UHFFFAOYSA-N hydroxymethyl propionaldehyde Natural products CCC(=O)CO GFAZHVHNLUBROE-UHFFFAOYSA-N 0.000 description 1
- 235000003248 hydroxytyrosol Nutrition 0.000 description 1
- 229940095066 hydroxytyrosol Drugs 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 229940076263 indole Drugs 0.000 description 1
- HAJKHJOABGFIGP-UHFFFAOYSA-N indolizidine Chemical compound C1CCCN2CCCC21 HAJKHJOABGFIGP-UHFFFAOYSA-N 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000007603 infrared drying Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- NNQSGBRGJHSRFN-UHFFFAOYSA-N isoflavan Chemical class C1OC2=CC=CC=C2CC1C1=CC=CC=C1 NNQSGBRGJHSRFN-UHFFFAOYSA-N 0.000 description 1
- 235000002324 isoflavanes Nutrition 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- BWXLCOBSWMQCGP-UHFFFAOYSA-N isohomovanillic acid Chemical compound COC1=CC=C(CC(O)=O)C=C1O BWXLCOBSWMQCGP-UHFFFAOYSA-N 0.000 description 1
- GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical compound C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N isomenthone Natural products CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical group C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 235000006826 lariciresinol Nutrition 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 229930013978 luteolinidin Natural products 0.000 description 1
- GDNIGMNXEKGFIP-UHFFFAOYSA-O luteolinidin Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=CC=1C1=CC=C(O)C(O)=C1 GDNIGMNXEKGFIP-UHFFFAOYSA-O 0.000 description 1
- 229940043353 maltol Drugs 0.000 description 1
- 235000009584 malvidin Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 235000000055 matairesinol Nutrition 0.000 description 1
- RNXYRAQIZQGUIK-UHFFFAOYSA-N matairesinol Natural products COc1cc(CC2OCC(=O)C2Cc3ccc(O)c(OC)c3)ccc1O RNXYRAQIZQGUIK-UHFFFAOYSA-N 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- OGFXBIXJCWAUCH-UHFFFAOYSA-N meso-secoisolariciresinol Natural products C1=2C=C(O)C(OC)=CC=2CC(CO)C(CO)C1C1=CC=C(O)C(OC)=C1 OGFXBIXJCWAUCH-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- GEWDNTWNSAZUDX-UHFFFAOYSA-N methyl 7-epi-jasmonate Natural products CCC=CCC1C(CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-UHFFFAOYSA-N 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- CCRCUPLGCSFEDV-BQYQJAHWSA-N methyl trans-cinnamate Chemical compound COC(=O)\C=C\C1=CC=CC=C1 CCRCUPLGCSFEDV-BQYQJAHWSA-N 0.000 description 1
- NWFYESYCEQICQP-UHFFFAOYSA-N methylmatairesinol Natural products C1=C(OC)C(OC)=CC=C1CC1C(=O)OCC1CC1=CC=C(O)C(OC)=C1 NWFYESYCEQICQP-UHFFFAOYSA-N 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- QQZOPKMRPOGIEB-UHFFFAOYSA-N n-butyl methyl ketone Natural products CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 1
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 1
- 235000007625 naringenin Nutrition 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- 239000003345 natural gas Substances 0.000 description 1
- 229930014802 neoflavonoid Natural products 0.000 description 1
- 150000002804 neoflavonoids Chemical class 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- DQRZXILSJKXVQV-UHFFFAOYSA-N nepalensinol G Natural products Oc1ccc(cc1)C2OC3=CC(=O)C(=O)C4=C3C2c5cc(O)cc(O)c5C(C4C6C(c7ccc(O)cc7)c8c(O)cc(O)cc8C9C(Oc%10cc(O)cc6c9%10)c%11ccc(O)cc%11)c%12ccc(O)cc%12 DQRZXILSJKXVQV-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- TZPBMNKOLMSJPF-UHFFFAOYSA-N o-O-beta-D-glucosylbenzoic acid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1C(O)=O TZPBMNKOLMSJPF-UHFFFAOYSA-N 0.000 description 1
- ILUJQPXNXACGAN-UHFFFAOYSA-N ortho-methoxybenzoic acid Natural products COC1=CC=CC=C1C(O)=O ILUJQPXNXACGAN-UHFFFAOYSA-N 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 description 1
- 235000006251 pelargonidin Nutrition 0.000 description 1
- YPVZJXMTXCOTJN-UHFFFAOYSA-N pelargonidin chloride Chemical compound [Cl-].C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 YPVZJXMTXCOTJN-UHFFFAOYSA-N 0.000 description 1
- IAFPTKYDGNATOK-UHFFFAOYSA-N pentazinane Chemical group N1NNNNC1 IAFPTKYDGNATOK-UHFFFAOYSA-N 0.000 description 1
- ALAGDBVXZZADSN-UHFFFAOYSA-N pentazine Chemical group C1=NN=NN=N1 ALAGDBVXZZADSN-UHFFFAOYSA-N 0.000 description 1
- 229930015721 peonidin Natural products 0.000 description 1
- 235000006404 peonidin Nutrition 0.000 description 1
- OGBSHLKSHNAPEW-UHFFFAOYSA-N peonidin chloride Chemical compound [Cl-].C1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 OGBSHLKSHNAPEW-UHFFFAOYSA-N 0.000 description 1
- RUMOYJJNUMEFDD-UHFFFAOYSA-N perillyl aldehyde Chemical compound CC(=C)C1CCC(C=O)=CC1 RUMOYJJNUMEFDD-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229930015717 petunidin Natural products 0.000 description 1
- 235000006384 petunidin Nutrition 0.000 description 1
- QULMBDNPZCFSPR-UHFFFAOYSA-N petunidin chloride Chemical compound [Cl-].OC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 QULMBDNPZCFSPR-UHFFFAOYSA-N 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229930182487 phenolic glycoside Natural products 0.000 description 1
- 150000007950 phenolic glycosides Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229940100595 phenylacetaldehyde Drugs 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- IOUVKUPGCMBWBT-UHFFFAOYSA-N phloridzosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-UHFFFAOYSA-N 0.000 description 1
- IOUVKUPGCMBWBT-QNDFHXLGSA-N phlorizin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-QNDFHXLGSA-N 0.000 description 1
- 235000019139 phlorizin Nutrition 0.000 description 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 1
- HSTZMXCBWJGKHG-OUUBHVDSSA-N piceide Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(C=CC=2C=CC(O)=CC=2)=C1 HSTZMXCBWJGKHG-OUUBHVDSSA-N 0.000 description 1
- URFCJEUYXNAHFI-ZDUSSCGKSA-N pinocembrin Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)O)=CC=CC=C1 URFCJEUYXNAHFI-ZDUSSCGKSA-N 0.000 description 1
- 235000007221 pinoresinol Nutrition 0.000 description 1
- OHOPKHNWLCMLSW-UHFFFAOYSA-N pinoresinol Natural products C1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(CO)C(O)=CC=3)CO2)=C1 OHOPKHNWLCMLSW-UHFFFAOYSA-N 0.000 description 1
- YCVPRTHEGLPYPB-UHFFFAOYSA-N pinosylvine Natural products OC1=CC(O)=CC(C=CC=2C=CC=CC=2)=C1 YCVPRTHEGLPYPB-UHFFFAOYSA-N 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 1
- YVCVYCSAAZQOJI-UHFFFAOYSA-N podophyllotoxin Natural products COC1=C(O)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YVCVYCSAAZQOJI-UHFFFAOYSA-N 0.000 description 1
- 229960001237 podophyllotoxin Drugs 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 229930008679 prenylflavonoid Natural products 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 1
- VLEUZFDZJKSGMX-ONEGZZNKSA-N pterostilbene Chemical compound COC1=CC(OC)=CC(\C=C\C=2C=CC(O)=CC=2)=C1 VLEUZFDZJKSGMX-ONEGZZNKSA-N 0.000 description 1
- VLEUZFDZJKSGMX-UHFFFAOYSA-N pterostilbene Natural products COC1=CC(OC)=CC(C=CC=2C=CC(O)=CC=2)=C1 VLEUZFDZJKSGMX-UHFFFAOYSA-N 0.000 description 1
- PMXCMJLOPOFPBT-HNNXBMFYSA-N purvalanol A Chemical compound C=12N=CN(C(C)C)C2=NC(N[C@@H](CO)C(C)C)=NC=1NC1=CC=CC(Cl)=C1 PMXCMJLOPOFPBT-HNNXBMFYSA-N 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- LJPZHJUSICYOIX-UHFFFAOYSA-N quinolizidine Chemical compound C1CCCC2CCCCN21 LJPZHJUSICYOIX-UHFFFAOYSA-N 0.000 description 1
- SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical group C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- BNUZUOWRDKPBQR-UHFFFAOYSA-N reticuline Natural products CN1CCC2=CC(OC)=CC=C2C1CC1=CC=C(OC)C(O)=C1 BNUZUOWRDKPBQR-UHFFFAOYSA-N 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- 229930002286 rosinidin Natural products 0.000 description 1
- GNONHFYAESLOCB-UHFFFAOYSA-O rosinidin Chemical compound [O+]=1C2=CC(OC)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(OC)=C1 GNONHFYAESLOCB-UHFFFAOYSA-O 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 235000004239 secoisolariciresinol Nutrition 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- KQRXQIPRDKVZPW-UHFFFAOYSA-N sesaminol Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=3OCOC=3C=C2O)=C1 KQRXQIPRDKVZPW-UHFFFAOYSA-N 0.000 description 1
- KQRXQIPRDKVZPW-ISZNXKAUSA-N sesaminol Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=3OCOC=3C=C2O)=C1 KQRXQIPRDKVZPW-ISZNXKAUSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- XJTXBUKLGQCZHC-GCKMJXCFSA-N steganacin Chemical compound C1=C2C=3C(OC)=C(OC)C(OC)=CC=3C[C@@H]3C(=O)OC[C@H]3[C@H](OC(C)=O)C2=CC2=C1OCO2 XJTXBUKLGQCZHC-GCKMJXCFSA-N 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- LVUPFEOCDSHRBL-UHFFFAOYSA-N syringaresinol Natural products COc1cccc(OC)c1C2OCC3C2COC3c4c(OC)cccc4OC LVUPFEOCDSHRBL-UHFFFAOYSA-N 0.000 description 1
- KOWMJRJXZMEZLD-UHFFFAOYSA-N syringaresinol Chemical compound COC1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(OC)C(O)=C(OC)C=3)CO2)=C1 KOWMJRJXZMEZLD-UHFFFAOYSA-N 0.000 description 1
- NPFVOOAXDOBMCE-UHFFFAOYSA-N trans-3-hexenyl acetate Natural products CCC=CCCOC(C)=O NPFVOOAXDOBMCE-UHFFFAOYSA-N 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- PERPNFLGJXUDDW-CUYWLFDKSA-N trans-astringin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(\C=C\C=2C=C(O)C(O)=CC=2)=C1 PERPNFLGJXUDDW-CUYWLFDKSA-N 0.000 description 1
- BJIOGJUNALELMI-UHFFFAOYSA-N trans-isoeugenol Natural products COC1=CC(C=CC)=CC=C1O BJIOGJUNALELMI-UHFFFAOYSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- PTNLHDGQWUGONS-OWOJBTEDSA-N trans-p-coumaryl alcohol Chemical compound OC\C=C\C1=CC=C(O)C=C1 PTNLHDGQWUGONS-OWOJBTEDSA-N 0.000 description 1
- HSTZMXCBWJGKHG-CUYWLFDKSA-N trans-piceid Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(\C=C\C=2C=CC(O)=CC=2)=C1 HSTZMXCBWJGKHG-CUYWLFDKSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000004330 tyrosol Nutrition 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- WCTNXGFHEZQHDR-UHFFFAOYSA-N valencene Natural products C1CC(C)(C)C2(C)CC(C(=C)C)CCC2=C1 WCTNXGFHEZQHDR-UHFFFAOYSA-N 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- DGNAGJFHEJITCF-IUAFFJJUSA-N vaticanol B Natural products Oc1ccc(cc1)[C@@H]2Oc3cc(O)c4[C@@H]([C@H]([C@@H]5[C@H](c6ccc(O)cc6)c7c(O)cc(O)cc7[C@@H]2c3c45)c8ccccc8)c9cc(O)cc%10O[C@@H]([C@@H](c%11cc(O)cc(O)c%11)c9%10)c%12ccc(O)cc%12 DGNAGJFHEJITCF-IUAFFJJUSA-N 0.000 description 1
- VOANMQWFRWOKSM-ATGKYDEGSA-N vaticanol b Chemical compound C1=CC(O)=CC=C1[C@H]1[C@H](C=2C=C(O)C=C(O)C=2)C2=C([C@H]3C4=C(O)C=C5O[C@H]([C@@H]6C7=CC(O)=CC(O)=C7[C@@H](C=7C=CC(O)=CC=7)[C@H](C4=C65)[C@@H]3C=3C=CC(O)=CC=3)C=3C=CC(O)=CC=3)C=C(O)C=C2O1 VOANMQWFRWOKSM-ATGKYDEGSA-N 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- BURBOJZOZGMMQF-UHFFFAOYSA-N xanthoxylol Natural products C1=C(O)C(OC)=CC=C1C1C(COC2C=3C=C4OCOC4=CC=3)C2CO1 BURBOJZOZGMMQF-UHFFFAOYSA-N 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Landscapes
- Extraction Or Liquid Replacement (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
本発明は、シキミ酸またはその誘導体の製造方法に関するものである。 The present invention relates to a method for producing shikimic acid or a derivative thereof.
芳香族カルボン酸化合物のような環式化合物は、例えばエンジニアリングプラスチックのような樹脂や薬品の原料の他、香料や化粧料またはそれらの原料として用いられている。 Cyclic compounds such as aromatic carboxylic acid compounds are used, for example, as raw materials for resins such as engineering plastics and pharmaceuticals, as well as for fragrances and cosmetics, or as raw materials for these.
このような環式化合物は、従来、石油、天然ガスおよび石炭のような化石資源を原料として製造される。また、近年では、化石資源の枯渇や二酸化炭素濃度の増加に伴う地球温暖化への懸念から、バイオマス資源を原料とすることが試みられている。 Such cyclic compounds are traditionally produced using fossil resources such as petroleum, natural gas, and coal as raw materials. In recent years, however, there have been attempts to use biomass resources as raw materials due to concerns over global warming caused by the depletion of fossil resources and the increase in carbon dioxide concentrations.
例えば、特許文献1には、バイオマスから微生物発酵によりメタンを製造した後、触媒反応によってメタンからベンゼンを製造し、さらにこのベンゼンからベンゼン誘導体を製造する方法が開示されている。このようにして製造されたベンゼン誘導体は、芳香族ポリマーの原料として用いられるため、化石資源に依存しないポリマーを実現することができる。 For example, Patent Document 1 discloses a method of producing methane from biomass by microbial fermentation, producing benzene from the methane by a catalytic reaction, and then producing a benzene derivative from the benzene. The benzene derivative produced in this way is used as a raw material for aromatic polymers, making it possible to realize polymers that are not dependent on fossil resources.
しかしながら、従来の方法は、ベンゼン誘導体の製造効率がまだ十分ではない。具体的には、バイオマスからメタンおよびベンゼンを経てベンゼン誘導体(例えばフタル酸等)を製造するため、投入する手間やエネルギーの割に、合成されるベンゼン誘導体の量が少ないという問題がある。 However, the conventional methods are still not efficient enough in producing benzene derivatives. Specifically, because benzene derivatives (such as phthalic acid) are produced from biomass via methane and benzene, there is a problem that the amount of benzene derivatives synthesized is small compared to the effort and energy input.
また、製造されるベンゼン誘導体の純度を高めることも求められている。特許文献1にはベンゼンを蒸留法等で精製することが開示されており、これによってベンゼン誘導体の純度を高めることが可能であるものの、その際には多くのエネルギーを消費する。 There is also a demand for increasing the purity of the benzene derivatives produced. Patent Document 1 discloses purifying benzene using a method such as distillation, which can increase the purity of the benzene derivatives, but this consumes a lot of energy.
本発明の目的は、固体で高純度のシキミ酸またはその誘導体を高い収率で製造可能な製造方法を提供することにある。 An object of the present invention is to provide a method for producing solid, highly pure shikimic acid or a derivative thereof in high yield.
このような目的は、下記(1)~(7)の本発明により達成される。
(1) シキミ酸またはその誘導体を含有する原料液体をバイオマスから調製する原料液体調製工程と、
前記原料液体に乾燥剤を入れた後、前記原料液体を減圧下に置いて真空乾燥させることにより、前記原料液体の濃縮を進行させる乾燥工程と、
前記原料液体に抽出用溶媒を入れてシキミ酸またはその誘導体を抽出し、抽出液を得る抽出工程と、
前記抽出液の溶質を固体として得る析出工程と、
前記析出工程の後に設けられ、前記溶質を良溶媒に溶解させる再溶解処理を施し、溶液を得る工程と、
前記溶液に活性炭処理を施す工程と、
前記活性炭処理が施された前記溶液に対し、貧溶媒を添加する再沈殿処理を施し、沈殿を固体として回収する工程と、
を有し、
前記原料液体に対し、前記乾燥剤および前記抽出用溶媒を添加することにより、前記乾燥工程および前記抽出工程を同時に行い、
回収された前記固体は、粉末状をなしており、JIS P 8148:2001に規定されたISO白色度の試験方法に準じて測定されたISO白色度が70%以上であることを特徴とするシキミ酸またはその誘導体の製造方法。
(2) 前記乾燥工程は、前記原料液体を濃縮してなる濃縮液に、前記乾燥剤を入れ、前記濃縮液をさらに濃縮する処理を含み、
前記乾燥剤の添加量は、前記濃縮液100gに対して1~300gである上記(1)に記載のシキミ酸またはその誘導体の製造方法。
(3) シキミ酸またはその誘導体を含有する原料液体をバイオマスから調製する原料液体調製工程と、
前記原料液体を真空乾燥させ、乾燥物を得る乾燥工程と、
前記乾燥物を良溶媒に溶解させる再溶解処理を施し、溶液を得る再溶解工程と、
前記溶液に活性炭処理を施す吸着工程と、
抽出用溶媒により、前記活性炭処理を施した前記溶液からシキミ酸またはその誘導体を液液抽出し、抽出液を得る抽出工程と、
前記抽出液の溶質を固体として回収する析出工程と、
を有し、
回収された前記固体は、粉末状をなしており、JIS P 8148:2001に規定されたISO白色度の試験方法に準じて測定されたISO白色度が70%以上であることを特徴とするシキミ酸またはその誘導体の製造方法。
(4) 前記析出工程の後に設けられ、前記溶質を良溶媒に溶解させる再溶解処理を施し、溶液を得る工程と、
前記溶液に活性炭処理を施す工程と、
前記活性炭処理が施された前記溶液に対し、貧溶媒を添加する再沈殿処理を施し、沈殿を固体として回収する工程と、
を有する上記(3)に記載のシキミ酸またはその誘導体の製造方法。
These objects can be achieved by the present invention described below in (1) to (7) .
(1) a raw material liquid preparation step of preparing a raw material liquid containing shikimic acid or a derivative thereof from biomass;
a drying step of adding a desiccant to the raw liquid and then vacuum-drying the raw liquid under reduced pressure to concentrate the raw liquid;
An extraction step of adding an extraction solvent to the raw material liquid to extract shikimic acid or a derivative thereof to obtain an extract;
a precipitation step of obtaining the solute of the extract as a solid;
a step of performing a re-dissolving process after the precipitation step, in which the solute is dissolved in a good solvent to obtain a solution;
subjecting the solution to an activated carbon treatment;
a step of subjecting the solution that has been treated with activated carbon to a reprecipitation treatment by adding a poor solvent and recovering a precipitate as a solid;
having
The drying step and the extraction step are carried out simultaneously by adding the desiccant and the extraction solvent to the raw material liquid;
A method for producing shikimic acid or a derivative thereof, characterized in that the recovered solid is in powder form and has an ISO whiteness of 70% or more as measured in accordance with the ISO whiteness test method specified in JIS P 8148:2001.
(2) the drying step includes a process of adding the desiccant to a concentrated liquid obtained by concentrating the raw material liquid, and further concentrating the concentrated liquid;
The method for producing shikimic acid or a derivative thereof according to (1) above , wherein the amount of the desiccant added is 1 to 300 g per 100 g of the concentrated solution .
(3) A raw material liquid preparation step of preparing a raw material liquid containing shikimic acid or a derivative thereof from biomass;
a drying step of vacuum drying the raw material liquid to obtain a dried product;
a redissolving step of dissolving the dried product in a good solvent to obtain a solution;
an adsorption step of subjecting the solution to an activated carbon treatment;
an extraction step of liquid-liquid extracting shikimic acid or a derivative thereof from the solution treated with the activated carbon using an extraction solvent to obtain an extract;
a precipitation step of recovering the solute from the extract as a solid;
having
A method for producing shikimic acid or a derivative thereof, characterized in that the recovered solid is in powder form and has an ISO whiteness of 70% or more as measured in accordance with the ISO whiteness test method specified in JIS P 8148:2001.
(4) a step of performing a re-dissolving process after the precipitation step, in which the solute is dissolved in a good solvent to obtain a solution;
subjecting the solution to an activated carbon treatment;
a step of subjecting the solution that has been treated with activated carbon to a reprecipitation treatment by adding a poor solvent and recovering a precipitate as a solid;
The method for producing shikimic acid or a derivative thereof according to (3) above,
(5) 前記乾燥物は、液相の含有率が30質量%以下である上記(3)または(4)に記載のシキミ酸またはその誘導体の製造方法。 (5) The method for producing shikimic acid or a derivative thereof according to (3) or (4) above, wherein the dried product has a liquid phase content of 30% by mass or less.
(6) 前記乾燥工程の前に設けられ、前記原料液体に酸を添加する酸性化工程をさらに有する上記(1)ないし(5)のいずれかに記載のシキミ酸またはその誘導体の製造方法。 (6) The method for producing shikimic acid or a derivative thereof according to any one of (1) to (5) above, further comprising an acidification step of adding an acid to the raw liquid, which is performed prior to the drying step.
(7) 前記析出工程は、前記抽出液に含まれる前記溶媒を蒸発させる工程である上記(1)ないし(6)のいずれかに記載のシキミ酸またはその誘導体の製造方法。 (7) A method for producing shikimic acid or a derivative thereof according to any one of (1) to (6) above, wherein the precipitation step is a step of evaporating the solvent contained in the extract.
本発明によれば、固体で高純度のシキミ酸またはその誘導体を高い収率で製造することができる。 According to the present invention, it is possible to produce solid, highly pure shikimic acid or a derivative thereof in high yield.
以下、本発明の環式化合物またはその誘導体の製造方法について添付図面に示す好適実施形態に基づいて詳細に説明する。 The method for producing the cyclic compound or its derivative of the present invention will be described in detail below based on the preferred embodiment shown in the attached drawings.
<環式化合物またはその誘導体の製造方法>
≪第1実施形態≫
まず、本発明の環式化合物またはその誘導体の製造方法の第1実施形態について説明する。
<Method for producing cyclic compound or derivative thereof>
First Embodiment
First, a first embodiment of the method for producing a cyclic compound or a derivative thereof of the present invention will be described.
図1は、本発明の環式化合物またはその誘導体の製造方法の第1実施形態を説明するための工程図である。 Figure 1 is a process diagram illustrating a first embodiment of the method for producing a cyclic compound or a derivative thereof of the present invention.
本実施形態に係る環式化合物またはその誘導体の製造方法(以下、省略して「環式化合物の製造方法」という。)は、バイオマスから原料液体を調製する原料液体調製工程S01と、原料液体に酸を添加する酸性化工程S02と、環式化合物またはその誘導体を含有する原料液体を乾燥させ、乾燥物を得る乾燥工程S03と、溶媒により、乾燥物から環式化合物またはその誘導体を抽出し、抽出液を得る抽出工程S04と、抽出液の溶質を固体として回収する析出工程S05と、を有する。このような環式化合物の製造方法によれば、固体で高純度の環式化合物またはその誘導体を高い収率で製造することができる。 The method for producing a cyclic compound or a derivative thereof according to this embodiment (hereinafter, abbreviated as "method for producing a cyclic compound") includes a raw liquid preparation step S01 for preparing a raw liquid from biomass, an acidification step S02 for adding an acid to the raw liquid, a drying step S03 for drying the raw liquid containing the cyclic compound or a derivative thereof to obtain a dried product, an extraction step S04 for extracting the cyclic compound or a derivative thereof from the dried product using a solvent to obtain an extract, and a precipitation step S05 for recovering the solute of the extract as a solid. According to this method for producing a cyclic compound, a solid, high-purity cyclic compound or a derivative thereof can be produced with a high yield.
以下、各工程について順次説明する。なお、以下の説明では、環式化合物またはその誘導体を省略して「環式化合物」ともいう。 Each step will be explained below. In the following explanation, cyclic compounds or their derivatives will be abbreviated to "cyclic compounds."
(原料液体調製工程S01)
特開2011-229544号公報に記載の方法でバイオマスから原料液体を調製する。
(Raw material liquid preparation step S01)
A raw material liquid is prepared from biomass by the method described in JP 2011-229544 A.
(酸性化工程S02)
次に、必要に応じて、得られた原料液体に酸を添加する。これにより、後述する工程において固体を回収するとき、結晶性の高い固体を得ることができる。このため、環式化合物の純度が高い固体を高い収率で回収することができる。
(Acidification step S02)
Next, an acid is added to the obtained raw material liquid as required. This allows a solid with high crystallinity to be obtained when the solid is recovered in the step described below. Therefore, a solid with high purity of the cyclic compound can be recovered in high yield.
酸添加後の原料液体のpHは、特に限定されないが、1.0~6.5程度であるのが好ましく、1.5~5.0程度であるのがより好ましい。これにより、後述する工程において固体を回収するとき、装置等の劣化を最小限に抑えつつ、純度の高い固体を高い収率で回収することが可能である。すなわち、装置等の劣化の抑制と回収する固体の高純度化および高収率化とを両立させることができる。 The pH of the raw liquid after the addition of acid is not particularly limited, but is preferably about 1.0 to 6.5, and more preferably about 1.5 to 5.0. This makes it possible to recover high purity solids at a high yield while minimizing deterioration of the equipment, etc., when recovering solids in the process described below. In other words, it is possible to achieve both suppression of deterioration of the equipment, etc., and high purity and high yield of the recovered solids.
添加する酸としては、例えば、ギ酸、酢酸、塩酸、プロピオン酸、酪酸、吉草酸等が挙げられる。これらの酸は、後述する乾燥工程において揮発除去されやすい。このため、原料液体の酸性化のために添加される酸として有用である。 Examples of acids that can be added include formic acid, acetic acid, hydrochloric acid, propionic acid, butyric acid, and valeric acid. These acids are easily removed by evaporation in the drying process described below. For this reason, they are useful as acids to be added to acidify the raw material liquid.
(乾燥工程S03)
次に、原料液体を乾燥させ、乾燥物を得る。
(Drying step S03)
Next, the raw liquid is dried to obtain a dry product.
原料液体を乾燥させる方法としては、例えば、煮沸乾燥法、噴霧乾燥法、伝熱乾燥法、赤外線乾燥法、温風乾燥法、真空乾燥法等が挙げられる。また、これらの乾燥法を含む複数種の乾燥法を組み合わせて適用するようにしてもよい。以下、代表的な4つの乾燥法について順次説明する。 Methods for drying the raw liquid include, for example, boiling drying, spray drying, heat transfer drying, infrared drying, hot air drying, and vacuum drying. In addition, a combination of multiple drying methods including these may be used. Below, four representative drying methods will be explained in order.
-煮沸乾燥法-
煮沸乾燥法(煮沸乾固法)は、例えばホットプレート等の加熱装置を用い、容器に入れた原料液体を加熱する。熱伝導で容器が加熱されると、原料液体中の溶媒が蒸発する。これにより、溶質が固体として析出する。溶媒の蒸発が進むと、固体が乾燥し、乾燥物が得られる。
- Boiling and drying method -
In the boiling and drying method, a raw liquid placed in a container is heated using a heating device such as a hot plate. When the container is heated by thermal conduction, the solvent in the raw liquid evaporates. This causes the solute to precipitate as a solid. As the solvent evaporates, the solid dries, and a dried product is obtained.
加熱温度は、溶媒が気化する温度以上に設定すればよいので、溶媒の種類に応じて異なるものの、例えば70~200℃程度であるのが好ましく、80~150℃程度であるのがより好ましい。これにより、環式化合物の変性や分解、着色等を抑制しつつ、溶媒を効率よく蒸発させることができる。 The heating temperature should be set to a temperature equal to or higher than the temperature at which the solvent evaporates, and although this varies depending on the type of solvent, it is preferable that the temperature is, for example, about 70 to 200°C, and more preferably about 80 to 150°C. This allows the solvent to evaporate efficiently while suppressing denaturation, decomposition, coloration, etc. of the cyclic compound.
加熱時間は、溶媒の蒸発の進行度合いに応じて適宜設定されるが、一例として10分~10時間程度であるのが好ましく、30分~6時間程度であるのがより好ましい。 The heating time is set appropriately depending on the degree of solvent evaporation, but as an example, it is preferably about 10 minutes to 10 hours, and more preferably about 30 minutes to 6 hours.
なお、加熱に伴う酸化を抑制するため、必要に応じて、非酸化性ガス下で加熱したり、非酸化性ガスを吹き付けながら加熱したりするようにしてもよい。 To suppress oxidation that occurs during heating, heating may be performed under a non-oxidizing gas or while spraying a non-oxidizing gas, if necessary.
このような煮沸乾燥法によれば、簡易的な装置を用いることができるので、製造コストの削減を図りやすいという利点がある。 This boiling and drying method has the advantage that it is possible to use simple equipment, making it easier to reduce manufacturing costs.
なお、得られた乾燥物は、必要に応じて、解砕または粉砕されるようにしてもよい。これにより、乾燥物の比表面積が大きくなるため、後述する抽出工程において環式化合物の抽出効率を高めることができる。 The obtained dried material may be crushed or pulverized as necessary. This increases the specific surface area of the dried material, thereby improving the extraction efficiency of the cyclic compounds in the extraction process described below.
-噴霧乾燥法-
噴霧乾燥法(スプレードライ法)は、例えば原料液体を乾燥室内のノズルで微粒化し、温風に接触させる(噴霧乾燥する)方法である。これにより、原料液体中の溶媒が蒸発するとともに、析出した溶質が粒子状に成形される。このため、取り扱いが容易な乾燥物が得られる。
- Spray drying method -
The spray drying method is a method in which, for example, a raw liquid is atomized using a nozzle in a drying chamber and then exposed to hot air (spray drying). As a result, the solvent in the raw liquid evaporates and the precipitated solute is formed into particles. This results in a dried product that is easy to handle.
また、乾燥に先立って原料液体を微粒化することから、原料液体の比表面積が大きくなる。このため、短時間で均一な昇温が可能になり、溶質の変性や分解等を最小限に留めることができる。加えて、かかる乾燥物は、後述する抽出工程において環式化合物の抽出効率が高いものとなる。 In addition, because the raw liquid is atomized prior to drying, the specific surface area of the raw liquid is increased. This allows for uniform heating in a short period of time, minimizing denaturation and decomposition of solutes. In addition, such dried material provides high extraction efficiency for cyclic compounds in the extraction process described below.
さらに、原料液体に対する熱伝導が温風を介したものであるため、昇温ムラが少なく、乾燥状態の均一化を図りやすいという利点もある。
また、原料液体の昇温効率が高く、エネルギー効率が高いという利点もある。
Furthermore, since heat is conducted to the raw material liquid via the hot air, there is little unevenness in the temperature rise, which has the advantage that it is easy to achieve a uniform drying state.
Another advantage is that the efficiency of raising the temperature of the raw material liquid is high, and energy efficiency is high.
なお、噴霧乾燥法で得られた乾燥物は、比較的粒径が揃った粒子となる。このため、その後の分級処理を省略したり、簡素化したりすることができ、製造コストを抑えつつ、流動性が高くて扱いやすい乾燥物を得ることができる。 The dried material obtained by the spray drying method has a relatively uniform particle size. This makes it possible to omit or simplify the subsequent classification process, and to obtain a dried material that is highly fluid and easy to handle while keeping production costs down.
製造される粒子状の乾燥物の平均粒径は、特に限定されないが、5~300μm程度であるのが好ましく、10~200μm程度であるのがより好ましい。これにより、後述する工程において処理効率が高く、かつ、流動性等の観点から扱いやすい乾燥物が得られる。 The average particle size of the particulate dried product produced is not particularly limited, but is preferably about 5 to 300 μm, and more preferably about 10 to 200 μm. This allows for a dried product to be obtained that is highly efficient in the process described below and is easy to handle in terms of flowability, etc.
また、温風の入口温度は、溶媒の沸点に応じて適宜設定されるが、一例として30~200℃程度であるのが好ましく、40~150℃程度であるのがより好ましい。 The inlet temperature of the hot air is set appropriately depending on the boiling point of the solvent, but is preferably about 30 to 200°C, and more preferably about 40 to 150°C, for example.
また、噴霧乾燥法では、閉空間で乾燥させることができるので、必要に応じて、窒素やアルゴンのような不活性ガス下で乾燥させることができる。これにより、乾燥物の酸化を抑制することができる。 In addition, since the spray drying method allows drying in a closed space, it is possible to dry the material under an inert gas such as nitrogen or argon, if necessary. This makes it possible to suppress oxidation of the dried material.
-伝熱乾燥法-
伝熱乾燥法(間接加熱乾燥法)は、例えば伝熱面を介して原料液体を間接的に加熱する方法である。これにより、伝熱面に接触した原料液体中の溶媒が蒸発し、乾燥物が得られる。
-Heat transfer drying method-
The heat transfer drying method (indirect heating drying method) is a method in which the raw material liquid is indirectly heated, for example, via a heat transfer surface, whereby the solvent in the raw material liquid in contact with the heat transfer surface evaporates, resulting in a dried product.
伝熱面としては、例えばディスク、ドラム、シリンダー等の形状をした金属体が挙げられる。伝熱乾燥法では、これらの伝熱面に原料液体が散布されると、短時間で乾燥し、伝熱面上に乾燥物が得られる。この乾燥物は、スクレーパーでかき落され、塊状物または粒状物として回収される。 Examples of heat transfer surfaces include metal bodies in the shape of a disk, drum, cylinder, etc. In the heat transfer drying method, when the raw liquid is sprayed onto these heat transfer surfaces, it dries in a short time, and a dried material is obtained on the heat transfer surface. This dried material is scraped off with a scraper and collected as lumps or granules.
また、乾燥に先立って原料液体を薄膜化することから、原料液体の比表面積が大きくなる。このため、短時間で均一な昇温が可能になり、溶質の変性や分解等を最小限に留めることができる。 In addition, the raw liquid is thinned prior to drying, which increases the specific surface area of the raw liquid. This allows the temperature to be raised uniformly in a short period of time, minimizing denaturation and decomposition of the solute.
なお、伝熱面の温度は、溶媒の沸点に応じて適宜設定されるが、例えば70~200℃程度であるのが好ましく、80~150℃程度であるのがより好ましい。これにより、環式化合物の変性や分解、着色等を抑制しつつ、溶媒を効率よく蒸発させることができる。 The temperature of the heat transfer surface is set appropriately depending on the boiling point of the solvent, but is preferably about 70 to 200°C, and more preferably about 80 to 150°C. This allows the solvent to evaporate efficiently while suppressing denaturation, decomposition, and coloring of the cyclic compound.
また、伝熱面を減圧下に置くようにしてもよい。これにより、溶媒の蒸発効率を高めるとともに、環式化合物の酸化や焦げ付き等を抑制することができる。 The heat transfer surface may also be placed under reduced pressure. This increases the efficiency of solvent evaporation and prevents oxidation and burning of the cyclic compound.
加熱時間は、溶媒の蒸発の進行度合いに応じて適宜設定されるが、一例として10分~10時間程度であるのが好ましく、30分~6時間程度であるのがより好ましい。 The heating time is set appropriately depending on the degree of solvent evaporation, but as an example, it is preferably about 10 minutes to 10 hours, and more preferably about 30 minutes to 6 hours.
なお、得られた乾燥物は、必要に応じて、解砕または粉砕されるようにしてもよい。これにより、乾燥物の比表面積が大きくなるため、後述する抽出工程において環式化合物の抽出効率を高めることができる。 The obtained dried material may be crushed or pulverized as necessary. This increases the specific surface area of the dried material, thereby improving the extraction efficiency of the cyclic compounds in the extraction process described below.
-真空乾燥法-
真空乾燥法は、原料液体を密閉容器に入れ、密閉容器内を減圧することによって、原料液体と容器内との溶媒分圧差を大きくし、乾燥を促進させる方法である。これにより、原料液体を短時間で確実に乾燥させ、乾燥物を得ることができる。加えて、低分子の不純物成分を効率よく除去することができるので、最終的に得られる環式化合物の純度や白色度を高めることができる。
- Vacuum drying method -
The vacuum drying method is a method in which the raw liquid is placed in a sealed container and the pressure in the container is reduced to increase the solvent partial pressure difference between the raw liquid and the inside of the container, thereby promoting drying. This allows the raw liquid to be dried reliably in a short time, and a dried product to be obtained. In addition, low molecular weight impurity components can be efficiently removed, so the purity and whiteness of the finally obtained cyclic compound can be increased.
また、真空乾燥法では、減圧下で処理されることから酸化や燃焼等が生じにくい。このため、環式化合物の酸化等の変性や焦げ付きによる着色等が抑制される。その結果、最終的に得られる環式化合物の純度や白色度を高めることができる。 In addition, in the vacuum drying method, oxidation and combustion are unlikely to occur because the process is carried out under reduced pressure. This prevents the cyclic compounds from being denatured by oxidation or discolored due to burning. As a result, the purity and whiteness of the final cyclic compounds can be improved.
なお、真空乾燥法では、必要に応じて、原料液体を加熱するようにしてもよい。その場合の加熱温度は、溶媒の沸点に応じて適宜設定されるが、一例として30~200℃程度であるのが好ましく、40~150℃程度であるのがより好ましい。 In addition, in the vacuum drying method, the raw liquid may be heated as necessary. In this case, the heating temperature is set appropriately according to the boiling point of the solvent, but as an example, it is preferably about 30 to 200°C, and more preferably about 40 to 150°C.
加熱時間は、溶媒の蒸発の進行度合いに応じて適宜設定されるが、一例として10分~24時間程度であるのが好ましく、30分~6時間程度であるのがより好ましい。 The heating time is set appropriately depending on the degree of solvent evaporation, but for example, it is preferably about 10 minutes to 24 hours, and more preferably about 30 minutes to 6 hours.
真空乾燥における密閉容器内の圧力は、大気圧未満であれば特に限定されないが、一例として100Pa以下であるのが好ましく、20Pa以下であるのがより好ましい。これにより、特に効率よく乾燥させることができるので、加熱に伴う環式化合物の変性等を最小限に留めることができる。また、酸化による変性や着色についても最小限に抑えることができる。 The pressure inside the sealed container during vacuum drying is not particularly limited as long as it is less than atmospheric pressure, but as an example, it is preferably 100 Pa or less, and more preferably 20 Pa or less. This allows for particularly efficient drying, and can minimize denaturation of cyclic compounds due to heating. In addition, denaturation and coloration due to oxidation can also be minimized.
なお、得られた乾燥物は、必要に応じて、解砕または粉砕されるようにしてもよい。これにより、乾燥物の比表面積が大きくなるため、後述する抽出工程において環式化合物の抽出効率を高めることができる。 The obtained dried material may be crushed or pulverized as necessary. This increases the specific surface area of the dried material, thereby improving the extraction efficiency of the cyclic compounds in the extraction process described below.
以上、4つの乾燥法について説明したが、本工程は上記のような各種乾燥法のように多くの液相を除去する工程に限定されず、一部が残存するような工程であってもよい。すなわち、不完全な乾燥物を得る工程であってもよい。 Although four drying methods have been described above, this process is not limited to a process that removes a large amount of liquid phase like the various drying methods described above, and may be a process in which some of the liquid phase remains. In other words, it may be a process that obtains an incompletely dried product.
乾燥物における液相の含有率は、30質量%以下であるのが好ましく、1質量%以上20質量%以下であるのがより好ましい。これにより、乾燥に要する時間やエネルギーが抑えられるため、効率のよい処理が可能になる。 The liquid phase content in the dried material is preferably 30% by mass or less, and more preferably 1% to 20% by mass. This reduces the time and energy required for drying, allowing for efficient processing.
また、液相の含有率を前記範囲内まで低下させることが可能であれば、上述した乾燥法に代えて、または乾燥法と併用するようにして、蒸留、吸着、抽出、膜分離、透析、逆浸透等の濃縮法を採用するようにしてもよい。濃縮法は、完全な乾燥を目的としないため、技術的な難易度や効率の観点において使いやすい。このため、より低コストかつ短時間で乾燥物を得ることができる。 In addition, if it is possible to reduce the liquid phase content to within the above range, a concentration method such as distillation, adsorption, extraction, membrane separation, dialysis, or reverse osmosis may be used in place of or in combination with the drying method described above. Concentration methods are easy to use in terms of technical difficulty and efficiency because they do not aim for complete drying. This makes it possible to obtain a dried product at a lower cost and in a shorter time.
なお、濃縮法によって液相の含有率を前記範囲内まで低下させる場合、濃縮の進行に伴って濃縮効率が徐々に低下するおそれがある。このような問題を踏まえ、濃縮法を採用する際には、必要に応じて、濃縮の最中に減圧操作と常圧復帰操作とを繰り返す処理を施すようにしてもよい。これにより、気泡の収縮と膨張とが生じ、含まれる気泡の上昇、破裂が促されるため、気泡を効率よく消滅させることができる。その結果、濃縮効率の低下を抑えることができる。 When the liquid phase content is reduced to the above range by the concentration method, there is a risk that the concentration efficiency will gradually decrease as the concentration proceeds. In consideration of this problem, when using the concentration method, a process of repeatedly reducing pressure and returning to normal pressure during concentration may be performed as necessary. This causes the air bubbles to contract and expand, promoting the rise and bursting of the contained air bubbles, thereby making it possible to efficiently eliminate the air bubbles. As a result, the decrease in concentration efficiency can be suppressed.
減圧操作における圧力は、特に限定されないが、0.1~100kPa程度であるのが好ましく、1~80kPa程度であるのがより好ましい。これにより、含まれる気泡を効率よく上昇させ、破裂させることができ、濃縮効率の低下を十分に抑えつつ、濃縮を促進させることができる。 The pressure in the decompression operation is not particularly limited, but is preferably about 0.1 to 100 kPa, and more preferably about 1 to 80 kPa. This allows the contained air bubbles to rise and burst efficiently, and promotes concentration while sufficiently suppressing a decrease in concentration efficiency.
また、減圧操作の時間と常圧復帰操作の時間の比率は、気泡の発生の程度や濃縮速度に応じて適宜調整されるが、一例として、1:10~10:1程度であるのが好ましい。これにより、効率よく気泡を除去することができる。 The ratio of the time for the depressurization operation to the time for the normal pressure return operation is adjusted appropriately depending on the degree of bubble generation and the concentration speed, but as an example, it is preferable for it to be about 1:10 to 10:1. This allows for efficient removal of bubbles.
また、減圧操作の時間は、特に限定されないが、一例として1~10秒程度であるのが好ましい。これにより、効率よく気泡を除去することができる。 The time for the decompression operation is not particularly limited, but is preferably about 1 to 10 seconds, for example. This allows air bubbles to be removed efficiently.
(抽出工程S04)
次に、溶媒により、乾燥物から環式化合物を固液抽出し、抽出液を得る。
(Extraction step S04)
Next, the cyclic compound is subjected to solid-liquid extraction from the dried product using a solvent to obtain an extract.
固液抽出処理は、乾燥物中に含まれている環式化合物について、溶媒に対する溶解性を利用して選択的に抽出する処理である。すなわち、環式化合物を溶解させる溶媒を用い、抽出物として環式化合物の溶液を得る処理である。これにより、溶媒側に環式化合物を選択的に移行させ、不純物については乾燥物中に残存させることができる。その結果、純度の高い環式化合物が精製される。 The solid-liquid extraction process is a process in which the cyclic compounds contained in the dried product are selectively extracted by utilizing their solubility in a solvent. In other words, it is a process in which a solvent that dissolves the cyclic compounds is used to obtain a solution of the cyclic compounds as an extract. This allows the cyclic compounds to be selectively transferred to the solvent side, while the impurities remain in the dried product. As a result, a highly pure cyclic compound is produced.
溶媒としては、例えば、水、メタノール、エタノール、イソプロパノール、アセトン、アセトニトリル、ヘキサン、クロロホルム、テトラヒドロフラン等が挙げられる。 Examples of solvents include water, methanol, ethanol, isopropanol, acetone, acetonitrile, hexane, chloroform, and tetrahydrofuran.
固液抽出処理の温度は、特に限定されないが、5~80℃程度であるのが好ましく、10~50℃程度であるのがより好ましい。これにより、溶媒の溶解度を最適化することができるので、抽出される環式化合物の純度と、抽出率(抽出能力)と、を両立させることができる。 The temperature of the solid-liquid extraction process is not particularly limited, but is preferably about 5 to 80°C, and more preferably about 10 to 50°C. This allows the solubility of the solvent to be optimized, making it possible to achieve both the purity of the extracted cyclic compounds and the extraction rate (extraction capacity).
すなわち、温度が前記下限値未満である場合、抽出率が低下するおそれがある。一方、温度が前記上限値を上回ると、不純物も移行しやすくなり、環式化合物の純度が低下するおそれがある。 That is, if the temperature is below the lower limit, the extraction rate may decrease. On the other hand, if the temperature exceeds the upper limit, impurities may also migrate more easily, and the purity of the cyclic compound may decrease.
また、固液抽出処理の時間は、温度に応じて適宜設定されるが、例えば30分~10時間程度とされる。
なお、加圧下において加熱することにより、抽出率を高めることもできる。
The time for the solid-liquid extraction process is appropriately set depending on the temperature, but is, for example, about 30 minutes to 10 hours.
The extraction rate can be increased by heating under pressure.
また、溶媒の量は、特に限定されないが、乾燥物1gに対して3~200g程度であるのが好ましく、10~50g程度であるのがより好ましい。これにより、溶媒の量が最適化される。すなわち、溶媒の量が前記下限値を下回ると、抽出物の溶解が飽和して、抽出しきれないおそれがある。一方、溶媒の量が前記上限値を上回ると、余剰の溶媒が生じて、無駄になるおそれがある。また、不純物の抽出量が多くなり、環式化合物の純度が低下するおそれがある。 The amount of solvent is not particularly limited, but is preferably about 3 to 200 g per 1 g of dried material, and more preferably about 10 to 50 g. This optimizes the amount of solvent. That is, if the amount of solvent is below the lower limit, the dissolution of the extract may become saturated and not all of the extract may be extracted. On the other hand, if the amount of solvent is above the upper limit, excess solvent may be produced and may be wasted. Also, the amount of impurities extracted may increase, and the purity of the cyclic compound may decrease.
なお、乾燥工程において濃縮法を採用した場合には、乾燥工程と抽出工程とを同時に行うようにしてもよい。具体的には、原料液体またはある程度濃縮した濃縮液に対し、シリカゲルのような乾燥剤と、固液抽出用の溶媒と、を添加するようにすればよい。これにより、濃縮を進行させつつ、同時に固液抽出処理を施すことができる。 When a concentration method is used in the drying process, the drying process and the extraction process may be carried out simultaneously. Specifically, a desiccant such as silica gel and a solvent for solid-liquid extraction may be added to the raw liquid or a liquid concentrate that has been concentrated to a certain extent. This allows the solid-liquid extraction process to be carried out simultaneously while the concentration is proceeding.
乾燥剤の添加量は、液相の量に応じて適宜設定され、特に限定されないが、例えば濃縮液100gに対して1~300g程度とされるのが好ましい。 The amount of desiccant added is set appropriately depending on the amount of liquid phase and is not particularly limited, but it is preferable to add about 1 to 300 g per 100 g of concentrated liquid.
(析出工程S05)
次に、環式化合物を含む抽出液の溶質を固体として析出させる。この析出処理は、抽出液を除去する処理であれば、いかなる処理であってもよい。
(Deposition step S05)
Next, the solute of the extract containing the cyclic compound is precipitated as a solid. This precipitation treatment may be any treatment that removes the extract.
具体的には、かかる析出工程は、抽出液に含まれる溶媒を蒸発させる工程(濃縮乾固)であるのが好ましい。このような処理によれば、加熱または減圧のような簡単な操作で、環式化合物を含む抽出液から固体を容易に析出させることができる。すなわち、抽出液に溶存している溶質の分離と乾燥とを同時に行うことができるので、高効率の処理が可能になる。 Specifically, the precipitation step is preferably a step of evaporating the solvent contained in the extract (concentration to dryness). This type of treatment allows a solid to be easily precipitated from the extract containing the cyclic compound by a simple operation such as heating or reducing pressure. In other words, separation and drying of the solute dissolved in the extract can be performed simultaneously, enabling highly efficient treatment.
このような蒸発処理には、例えば加熱方式、減圧方式、ガス吹付方式等が挙げられ、これらのうちの複数方式を組み合わせるようにしてもよい。 Examples of such evaporation processes include heating, decompression, and gas spraying, and a combination of several of these methods may be used.
このうち、抽出液を加熱して揮発させる方式が好ましく用いられる。加熱温度は、抽出液を揮発させ得る温度であり、かつ、環式化合物の融点を下回る温度であれば、特に限定されないが、例えば50~300℃程度であるのが好ましく、80~250℃程度であるのがより好ましい。これにより、環式化合物の変質を抑制しつつ、抽出液を効率よく除去することができる。 Of these, the method of heating the extract to volatilize it is preferably used. The heating temperature is not particularly limited as long as it is a temperature at which the extract can be volatilized and is below the melting point of the cyclic compound, but is preferably about 50 to 300°C, and more preferably about 80 to 250°C. This makes it possible to efficiently remove the extract while suppressing deterioration of the cyclic compound.
また、溶媒を蒸発させる処理以外の方法で固体を析出させるようにしてもよい。
かかる方法としては、例えば、抽出液に溶存している環式化合物の溶解度を低下させる操作を行うことによって、環式化合物を選択的に析出させる晶析処理が挙げられる。晶析処理によれば、環式化合物の精製が図られるため、さらに高純度の環式化合物を析出させることが可能になる。
Furthermore, a solid may be precipitated by a method other than the process of evaporating the solvent.
As such a method, for example, a crystallization process is mentioned, in which the solubility of the cyclic compound dissolved in the extract is reduced to selectively precipitate the cyclic compound. The crystallization process refines the cyclic compound, so that it becomes possible to precipitate a cyclic compound with a higher purity.
晶析処理は、原料液体において特定の溶質を固体として析出させる処理であれば、いかなる方法であってもよい。 The crystallization process may be any process that causes a specific solute to precipitate as a solid in the raw liquid.
具体的には、例えば、原料液体の温度を変化させ溶解度の温度依存性を利用して晶析する処理、加熱または減圧等の操作により原料液体から溶媒を揮発除去し晶析する処理、溶質の溶解度が低い溶媒を添加し溶解度の溶媒種依存性を利用して晶析する処理、原料溶液のpHを変化させ溶解度のpH応答性を利用して晶析する処理等が挙げられ、これらのうちの1種または複数種を組み合わせて用いられる。 Specific examples include a process in which the temperature of the raw liquid is changed to utilize the temperature dependency of solubility for crystallization, a process in which the solvent is evaporated from the raw liquid by heating or reducing pressure, etc., a process in which a solvent in which the solute has low solubility is added to utilize the solvent-type dependency of solubility for crystallization, and a process in which the pH of the raw solution is changed to utilize the pH responsiveness of solubility for crystallization, and the like. One or a combination of these processes can be used.
例えばpH応答性を利用して晶析する処理を用いる場合、環式化合物は一般に低pHにおいて水への溶解度が低下する。したがって、晶析処理においてpHを例えば1~4程度まで下げることにより、溶解度を低下させ、環式化合物を析出させることができる。 For example, when using a crystallization process that utilizes pH responsiveness, the solubility of cyclic compounds in water generally decreases at low pH. Therefore, by lowering the pH in the crystallization process to, for example, about 1 to 4, the solubility can be reduced and the cyclic compounds can be precipitated.
このときの温度は、特に限定されないが、例えば15~80℃程度であるのが好ましく、20~60℃程度であるのがより好ましい。これにより、晶析処理の能力と収率とを両立することができる。 The temperature at this time is not particularly limited, but is preferably about 15 to 80°C, and more preferably about 20 to 60°C. This allows both the crystallization process capacity and yield to be achieved.
また、晶析操作は、バッチ操作であっても連続操作であってもよい。
また、晶析操作には、公知の撹拌槽が用いられる。
The crystallization process may be a batch process or a continuous process.
For the crystallization operation, a known stirring tank is used.
また、晶析を促進させるため、必要に応じて、析出させようとする固体の成分を含む種晶を添加するようにしてもよい。これにより、種晶が核となって晶析が促進され、晶析効率を高めるとともに、高純度化が図られやすくなる。
なお、晶析処理後には、固液分離処理によって、抽出液中の固体を分離すればよい。
In order to promote crystallization, seed crystals containing the solid components to be precipitated may be added as necessary. This promotes crystallization with the seed crystals acting as nuclei, thereby increasing the crystallization efficiency and facilitating high purity.
After the crystallization treatment, the solids in the extract may be separated by a solid-liquid separation treatment.
固液分離処理としては、例えば、ろ過分離、沈降分離、減圧脱水、加圧脱水等が挙げられるが、特に操作の容易さや分離の正確性の観点からろ過分離が好ましく用いられる。具体的には、遠心ろ過機を用いることができる。
また、固液分離操作は、バッチ操作であっても連続操作であってもよい。
Examples of solid-liquid separation treatments include filtration, sedimentation, dehydration under reduced pressure, and dehydration under pressure, among which filtration is particularly preferred from the viewpoints of ease of operation and accuracy of separation. Specifically, a centrifugal filter can be used.
The solid-liquid separation operation may be a batch operation or a continuous operation.
その後、必要に応じて、貧溶媒を用いて洗浄操作を行った後、乾燥させることにより、固体の環式化合物を回収することができる。
なお、上述した晶析操作に先立ち、濃縮処理を施すようにしてもよい。
Thereafter, if necessary, washing is carried out with a poor solvent, and then drying is carried out, whereby a solid cyclic compound can be recovered.
Prior to the above crystallization procedure, a concentration treatment may be carried out.
(その他の工程)
また、回収した固体の環式化合物は、追加的に設けられるその他の処理を行う工程に供されてもよい。
(Other processes)
The recovered solid cyclic compound may also be subjected to other additional processing steps.
その他の処理としては、例えば、再溶解処理、活性炭処理、再沈殿処理等が挙げられる。 Other treatments include, for example, redissolution treatment, activated carbon treatment, reprecipitation treatment, etc.
-再溶解処理-
再溶解処理は、回収した環式化合物を良溶媒に溶解させる処理である。これにより、環式化合物の溶液が調製される。
良溶媒としては、例えば、水、メタノール、ヘキサン、クロロホルム等が挙げられる。
-Remelting process-
The re-dissolving process is a process in which the recovered cyclic compound is dissolved in a good solvent, thereby preparing a solution of the cyclic compound.
Examples of good solvents include water, methanol, hexane, and chloroform.
-活性炭処理-
次に、調製した溶液に活性炭処理を施す。これにより、溶液中の高分子成分が活性炭に吸着され、除去される。なお、活性炭に代えて、その他の吸着媒体を用いるようにしてもよいが、活性炭が好ましく用いられる。
- Activated carbon treatment -
Next, the prepared solution is treated with activated carbon. As a result, the polymer components in the solution are adsorbed by the activated carbon and removed. Note that, although other adsorption media may be used instead of activated carbon, activated carbon is preferably used.
溶液に活性炭を添加し、撹拌する。活性炭を用いることにより、溶液の溶質について脱色することもできる。 Add activated charcoal to the solution and stir. Activated charcoal can also be used to decolorize the solutes in the solution.
なお、活性炭処理の温度は、30~150℃程度であるのが好ましい。また、活性炭処理の時間は、特に限定されないが、10分~10時間程度であるのが好ましい。 The temperature for the activated carbon treatment is preferably about 30 to 150°C. The time for the activated carbon treatment is not particularly limited, but is preferably about 10 minutes to 10 hours.
また、溶液100gに対する活性炭の添加量は、特に限定されないが、0.01~3gであるのが好ましく、0.1~1gであるのがより好ましい。これにより、溶質までが活性炭に吸着されてしまうのを抑制しつつ、十分な脱色作用を享受することができる。 The amount of activated carbon added per 100 g of solution is not particularly limited, but is preferably 0.01 to 3 g, and more preferably 0.1 to 1 g. This prevents the solute from being adsorbed by the activated carbon, while still providing sufficient decolorization.
なお、活性炭処理は必要に応じて行えばよく、省略されてもよい。また、活性炭処理の順序は、本実施形態に限定されず、例えば乾燥工程の前であってもよく、抽出工程と析出工程との間であってもよい。
また、処理後の活性炭は、ろ過等の固液分離によって除去される。
The activated carbon treatment may be performed as necessary, and may be omitted. The order of the activated carbon treatment is not limited to that of the present embodiment, and may be performed, for example, before the drying step or between the extraction step and the precipitation step.
After the treatment, the activated carbon is removed by solid-liquid separation such as filtration.
-再沈殿処理-
再沈殿処理は、調製した溶液に対し、環式化合物の貧溶媒を添加して、環式化合物の沈殿を得る処理である。すなわち、溶液に貧溶媒を添加して、環式化合物の溶解度を下げ、固体として析出させる処理である。これにより、環式化合物を選択的に沈殿させることができるため、高純度化を図ることができる。
-Reprecipitation treatment-
The reprecipitation process is a process in which a poor solvent for the cyclic compound is added to the prepared solution to obtain a precipitate of the cyclic compound. That is, a poor solvent is added to the solution to reduce the solubility of the cyclic compound, causing it to precipitate as a solid. This allows the cyclic compound to be selectively precipitated, thereby achieving high purity.
析出させた固体は、固液分離処理によって分離した後、乾燥させることによって固体の環式化合物として回収される。 The precipitated solid is separated by solid-liquid separation and then dried to recover the solid cyclic compound.
貧溶媒としては、水と混和しかつ水よりもシキミ酸の溶解度が低い溶媒であれば、特に限定されないが、例えば、エタノール、アセトニトリル、アセトン、イソプロパノール、酢酸エチル等が挙げられる。 The poor solvent is not particularly limited as long as it is miscible with water and has a lower solubility for shikimic acid than water, but examples of the poor solvent include ethanol, acetonitrile, acetone, isopropanol, and ethyl acetate.
≪第2実施形態≫
次に、本発明の環式化合物またはその誘導体の製造方法の第2実施形態について説明する。
Second Embodiment
Next, a second embodiment of the method for producing a cyclic compound or a derivative thereof of the present invention will be described.
図2は、本発明の環式化合物またはその誘導体の製造方法の第2実施形態を説明するための工程図である。なお、図2で用いている符号のうち、図1と同じ符号の工程は、第1実施形態で説明した工程と同様であることを示している。 Figure 2 is a process diagram for explaining a second embodiment of the method for producing a cyclic compound or a derivative thereof of the present invention. Note that among the symbols used in Figure 2, the steps with the same symbols as those in Figure 1 indicate that they are the same as the steps explained in the first embodiment.
以下、第2実施形態について説明するが、以下の説明では、第1実施形態との相違点を中心に説明し、同様の事項についてはその説明を省略する。 The second embodiment will be described below, but in the following explanation, the differences from the first embodiment will be mainly described, and explanations of similar points will be omitted.
本実施形態に係る環式化合物またはその誘導体の製造方法は、バイオマスから原料液体を調製する原料液体調製工程S01と、原料液体に酸を添加する酸性化工程S02と、環式化合物またはその誘導体を含有する原料液体を乾燥させ、乾燥物を得る乾燥工程S03と、乾燥物を再溶解し、溶液を得る再溶解工程S06と、溶液に吸着処理を施し、処理液を得る吸着工程S07と、処理液から環式化合物またはその誘導体を抽出し、抽出液を得る抽出工程S08と、抽出液の溶質を固体として回収する析出工程S05と、を有している。このような環式化合物の製造方法によれば、固体で高純度の環式化合物またはその誘導体を高い収率で製造することができる。 The method for producing a cyclic compound or a derivative thereof according to this embodiment includes a raw liquid preparation step S01 for preparing a raw liquid from biomass, an acidification step S02 for adding an acid to the raw liquid, a drying step S03 for drying the raw liquid containing the cyclic compound or a derivative thereof to obtain a dried product, a redissolution step S06 for redissolving the dried product to obtain a solution, an adsorption step S07 for subjecting the solution to an adsorption treatment to obtain a treated liquid, an extraction step S08 for extracting the cyclic compound or a derivative thereof from the treated liquid to obtain an extract, and a precipitation step S05 for recovering the solute of the extract as a solid. According to this method for producing a cyclic compound, a solid, high-purity cyclic compound or a derivative thereof can be produced with a high yield.
以下、各工程について順次説明する。なお、以下の説明では、環式化合物またはその誘導体を省略して「環式化合物」ともいう。 Each step will be explained below. In the following explanation, cyclic compounds or their derivatives will be abbreviated to "cyclic compounds."
(原料液体調製工程S01)
まず、第1実施形態と同様にして、原料液体を調製する。
(Raw material liquid preparation step S01)
First, a liquid source is prepared in the same manner as in the first embodiment.
(酸性化工程S02)
次に、必要に応じて、第1実施形態と同様にして、得られた原料液体に酸を添加する。
(Acidification step S02)
Next, as necessary, an acid is added to the obtained raw material liquid in the same manner as in the first embodiment.
(乾燥工程S03)
次に、第1実施形態と同様にして、原料液体を乾燥させ、乾燥物を得る。
(Drying step S03)
Next, in the same manner as in the first embodiment, the raw material liquid is dried to obtain a dried product.
(再溶解工程S06)
次に、必要に応じて、乾燥物を良溶媒に溶解する処理を施す。これにより、環式化合物の溶液が調製される。
良溶媒としては、例えば、水、メタノール、ヘキサン、クロロホルム等が挙げられる。
(Redissolving step S06)
Next, if necessary, the dried product is dissolved in a good solvent to prepare a solution of the cyclic compound.
Examples of good solvents include water, methanol, hexane, and chloroform.
(吸着工程S07)
次に、調製した溶液に活性炭処理等の吸着処理を施す。この活性炭処理は、第1実施形態に係る活性炭処理と同様である。これにより、溶液中の高分子成分が活性炭に吸着され、除去される。なお、活性炭に代えて、その他の吸着媒体を用いるようにしてもよいが、活性炭が好ましく用いられる。
(Adsorption step S07)
Next, the prepared solution is subjected to an adsorption treatment such as an activated carbon treatment. This activated carbon treatment is the same as the activated carbon treatment according to the first embodiment. As a result, the polymer components in the solution are adsorbed by the activated carbon and removed. Note that, although other adsorption media may be used instead of activated carbon, activated carbon is preferably used.
なお、本工程は必要に応じて行えばよく、省略されてもよい。また、本工程の順序は、本実施形態における順序に限定されず、例えば乾燥工程の前であってもよく、抽出工程と析出工程との間であってもよく、双方であってもよい。 This step may be performed as necessary, and may be omitted. The order of this step is not limited to that in this embodiment, and may be performed, for example, before the drying step, between the extraction step and the precipitation step, or both.
また、処理後の活性炭は、ろ過等の固液分離によって除去される。これにより、不純物等の少なくとも一部が除去された環式化合物の溶液が得られる。 After the treatment, the activated carbon is removed by solid-liquid separation such as filtration. This results in a solution of the cyclic compound from which at least some of the impurities have been removed.
(抽出工程S04)
次に、有機溶媒により、溶液、すなわち乾燥工程S03で得られた乾燥物を再溶解処理および吸着処理に供した結果、乾燥物が溶解してなる液体から環式化合物の液液抽出処理を施し、抽出液を得る。
(Extraction step S04)
Next, the solution, i.e., the dried product obtained in the drying step S03, is subjected to a re-dissolution process and an adsorption process using an organic solvent, and the liquid resulting from dissolving the dried product is subjected to a liquid-liquid extraction process of the cyclic compound to obtain an extract.
液液抽出処理は、溶液中に含まれている環式化合物および無機塩等の不純物について、有機溶媒に対する溶解性の違いを利用して、環式化合物を選択的に抽出する処理である。すなわち、環式化合物を溶解させる有機溶媒を用い、抽出物として環式化合物の溶液を得る処理である。これにより、有機溶媒側に環式化合物を選択的に移行させ、無機塩等の不純物については、当初の溶液中に含まれていた溶媒中に残存させることができる。その結果、純度の高い環式化合物が精製される。 Liquid-liquid extraction is a process that selectively extracts cyclic compounds by utilizing the difference in solubility in an organic solvent between cyclic compounds and impurities such as inorganic salts contained in a solution. In other words, it is a process that uses an organic solvent that dissolves cyclic compounds to obtain a solution of the cyclic compounds as an extract. This allows the cyclic compounds to be selectively transferred to the organic solvent, while impurities such as inorganic salts can be left in the solvent that was originally contained in the solution. As a result, a highly pure cyclic compound is produced.
有機溶媒としては、例えば、n-ブタノール、イソブタノール、イソ-n-ペンタノール、イソペンチルアルコール、n-ヘキサノール、2-ヘキサノール、クロロホルム、ヘキサン、ジエチルエーテル、ジクロロメタン、四塩化炭素等が挙げられる。 Examples of organic solvents include n-butanol, isobutanol, iso-n-pentanol, isopentyl alcohol, n-hexanol, 2-hexanol, chloroform, hexane, diethyl ether, dichloromethane, and carbon tetrachloride.
なお、この抽出工程では、上述した液液抽出処理に代えて、第1実施形態と同様の固液抽出処理を施すようにしてもよい。その場合、吸着工程S07で得られた溶液を、一度、固体化するために第2の乾燥工程を行うようにしてもよい。その第2の乾燥工程は、第1実施形態に係る乾燥工程と同様にして行えばよい。 In addition, in this extraction process, instead of the liquid-liquid extraction process described above, a solid-liquid extraction process similar to that of the first embodiment may be performed. In that case, a second drying process may be performed to solidify the solution obtained in the adsorption process S07. The second drying process may be performed in the same manner as the drying process according to the first embodiment.
(析出工程S05)
次に、第1実施形態と同様にして、環式化合物を含む抽出液の溶質を析出させ、必要に応じて、洗浄、乾燥を経ることにより、固体の環式化合物を回収することができる。
(Deposition step S05)
Next, in the same manner as in the first embodiment, the solute of the extract containing the cyclic compound is precipitated, and if necessary, washed and dried, whereby the solid cyclic compound can be recovered.
その後、必要に応じて、第1実施形態と同様の、その他の工程を行うようにしてもよい。 Thereafter, other steps similar to those in the first embodiment may be performed as necessary.
<環式化合物またはその誘導体>
次に、本発明の環式化合物またはその誘導体の実施形態について説明する。
<Cyclic Compound or Derivative>
Next, embodiments of the cyclic compound or a derivative thereof of the present invention will be described.
本実施形態に係る環式化合物またはその誘導体は、例えば下記式(1)で表される化合物である。 The cyclic compound or its derivative according to this embodiment is, for example, a compound represented by the following formula (1).
なお、環式化合物の誘導体とは、上記式(1)で表される化合物、上記式(1)で表される化合物から誘導される化合物、および、上記式(1)で表される化合物の塩のうちのいずれか、またはこれらの2種以上が混在したものである。 The derivative of a cyclic compound is any one of the compounds represented by the above formula (1), compounds derived from the compounds represented by the above formula (1), and salts of the compounds represented by the above formula (1), or a mixture of two or more of these.
上記式(1)で表される化合物から誘導される化合物としては、上記式(1)で表される化合物のエステル、酸無水物、アミド、酸ハロゲン化物等が挙げられる。なお、エステルには、例えば、メチルエステル、エチルエステル、プロピルエステル、ブチルエステル等が挙げられる。 Compounds derived from the compound represented by formula (1) above include esters, acid anhydrides, amides, acid halides, etc. of the compound represented by formula (1). Examples of esters include methyl esters, ethyl esters, propyl esters, and butyl esters.
上記式(1)で表される化合物の塩としては、ナトリウム塩、カリウム塩、アンモニウム塩等が挙げられる。 Examples of salts of the compound represented by the above formula (1) include sodium salts, potassium salts, ammonium salts, etc.
また、このような環式化合物は、バイオマス由来であって、粉末状をなしているものが好ましく用いられる。これにより、環境負荷が少なく、取り扱いが容易な化成品または化成品原料を得ることができる。 In addition, such cyclic compounds are preferably derived from biomass and are in powder form. This makes it possible to obtain chemical products or chemical product raw materials that have a low environmental impact and are easy to handle.
また、かかる環式化合物は、JIS P 8148:2001に規定されたISO白色度の試験方法に準じて測定されたISO白色度が70%以上であることが好ましく、80%以上であるのがより好ましい。このような環式化合物は、バイオマス由来であっても不純物が少ない化成品または化成品原料となる。特に、淡色の化成品を製造する場合等には、原料の色が化成品に移行するのを防ぐことが求められる。このような場合に、ISO白色度が前記範囲内である環式化合物を用いることにより、呈色不良が発生しにくく、高品質な化成品を得ることができる。 In addition, such cyclic compounds preferably have an ISO whiteness of 70% or more, more preferably 80% or more, measured according to the ISO whiteness test method specified in JIS P 8148:2001. Such cyclic compounds are chemical products or chemical raw materials with few impurities even if derived from biomass. In particular, when producing light-colored chemical products, it is necessary to prevent the color of the raw materials from transferring to the chemical product. In such cases, by using cyclic compounds with an ISO whiteness within the above range, color defects are less likely to occur and high-quality chemical products can be obtained.
なお、ISO白色度は、分光色彩白度計(例えば日本電色工業(株)製PF7000R)を用い、JIS P 8148:2001の「ISO白色度(拡散青色光反射率)の測定方法」に準拠して測定される。 The ISO whiteness is measured using a spectrophotometer (e.g., PF7000R manufactured by Nippon Denshoku Industries Co., Ltd.) in accordance with JIS P 8148:2001 "Method of measurement of ISO whiteness (diffuse blue light reflectance)".
ここで、式(1)で表される化合物についてさらに説明する。
飽和環、部分飽和環もしくは芳香環の5員環としては、例えば、フラン構造、チオフェン構造、ピロール構造、ピロリジン構造、テトラヒドロフラン構造、2,3-ジヒドロフラン構造、ピラゾール構造、イミダゾール構造、オキサゾール構造、イソオキサゾール構造、チアゾール構造、イソチアゾール構造等が挙げられる。
Here, the compound represented by formula (1) will be further explained.
Examples of the saturated ring, partially saturated ring, or aromatic 5-membered ring include a furan structure, a thiophene structure, a pyrrole structure, a pyrrolidine structure, a tetrahydrofuran structure, a 2,3-dihydrofuran structure, a pyrazole structure, an imidazole structure, an oxazole structure, an isoxazole structure, a thiazole structure, and an isothiazole structure.
飽和環の6員環としては、例えば、シクロヘキサン構造のような炭化水素系飽和環、ピペリジン構造、ピペラジン構造、トリアジナン構造、テトラジナン構造、ペンタジナン構造、キヌクリジン構造のような含窒素飽和環、テトラヒドロピラン構造、モルホリン構造のような含酸素飽和環、テトラヒドロチオピラン構造のような含硫黄飽和環等が挙げられる。 Examples of the six-membered saturated ring include hydrocarbon-based saturated rings such as a cyclohexane structure, nitrogen-containing saturated rings such as a piperidine structure, piperazine structure, triazinane structure, tetraazinane structure, pentazinane structure, and quinuclidine structure, oxygen-containing saturated rings such as a tetrahydropyran structure and a morpholine structure, and sulfur-containing saturated rings such as a tetrahydrothiopyran structure.
部分飽和環の6員環としては、シクロヘキセン構造、シクロヘキサジエン構造のような炭化水素系部分飽和環、ピペリジン構造のような含窒素部分飽和環、ピラン構造のような含酸素部分飽和環、チアジン構造のような含硫黄部分飽和環等が挙げられる。 Examples of the six-membered partially saturated ring include hydrocarbon partially saturated rings such as a cyclohexene structure or a cyclohexadiene structure, nitrogen-containing partially saturated rings such as a piperidine structure, oxygen-containing partially saturated rings such as a pyran structure, and sulfur-containing partially saturated rings such as a thiazine structure.
芳香環の6員環としては、ベンゼン構造のような炭化水素系芳香環、ピリジン構造、ピリダジン構造、ピリミジン構造、ピラジン構造、トリアジン構造、テトラジン構造、ペンタジン構造のような含窒素芳香環(含窒素不飽和環)等が挙げられる。 Examples of the six-membered aromatic ring include hydrocarbon aromatic rings such as a benzene structure, and nitrogen-containing aromatic rings (nitrogen-containing unsaturated rings) such as a pyridine structure, pyridazine structure, pyrimidine structure, pyrazine structure, triazine structure, tetrazine structure, and pentazine structure.
縮合環としては、例えば6員環と5員環との縮合環、2つの6員環の縮合環等が挙げられる。このうち、6員環と5員環との縮合環としては、例えば、インドール、インドレニン、インドリン、イソインドール、イソインドレニン、イソインドリン、イソドリジン、プリン、インドリジジンのようなインドール系構造が挙げられる。また、2つの6員環の縮合環としては、例えば、キノリン、イソキノリン、キノリジジン、キノキサリン、シンノリン、キナゾリン、フタラジン、ナフチリジン、プテリジンのようなキノリン系構造が挙げられる。 Examples of fused rings include a fused ring of a 6-membered ring and a 5-membered ring, and a fused ring of two 6-membered rings. Of these, examples of fused rings of a 6-membered ring and a 5-membered ring include indole-based structures such as indole, indolenine, indoline, isoindole, isoindolenine, isoindoline, isodolizine, purine, and indolizidine. Examples of fused rings of two 6-membered rings include quinoline-based structures such as quinoline, isoquinoline, quinolizidine, quinoxaline, cinnoline, quinazoline, phthalazine, naphthyridine, and pteridine.
Xは、単結合または1つ以上の炭素数を含む結合である。
Xが単結合である場合、環Aの環構成原子に対して酸素原子が直接結合している。
X is a single bond or a bond containing one or more carbon atoms.
When X is a single bond, the oxygen atom is directly bonded to a ring-constituting atom of ring A.
一方、1つ以上の炭素数を含む結合としては、例えば、炭素数1~4の炭化水素基、エーテル結合、エステル結合、アミド結合、カルボニル基、ビニリデン基等が挙げられ、これらのうちの1種または2種以上を組み合わせたものとされる。 On the other hand, examples of bonds containing one or more carbon atoms include hydrocarbon groups having 1 to 4 carbon atoms, ether bonds, ester bonds, amide bonds, carbonyl groups, vinylidene groups, etc., and these may be used alone or in combination of two or more.
このうち、炭素数1~4の炭化水素基は、直鎖または分枝鎖のいずれであってもよく、飽和または不飽和のいずれであってもよい。なお、炭化水素基の水素原子は、炭素数1~2のアルキル基、水酸基、アミノ基、カルボキシル基、ハロゲン原子等の置換基で置換されていてもよい。 Of these, the hydrocarbon group having 1 to 4 carbon atoms may be either linear or branched, and may be either saturated or unsaturated. The hydrogen atom of the hydrocarbon group may be substituted with a substituent such as an alkyl group having 1 to 2 carbon atoms, a hydroxyl group, an amino group, a carboxyl group, or a halogen atom.
なお、Xには、上述した結合に加え、任意の原子または原子団が含まれていてもよい。例えば、Xは、カルボニル基および1つ以上の炭素数を含む結合を含む原子団であってもよい。 In addition to the bonds described above, X may contain any atom or atomic group. For example, X may be an atomic group that contains a carbonyl group and a bond containing one or more carbon atoms.
Yは、水素原子またはアルキル基である。アルキル基の炭素数は好ましくは1~12とされ、より好ましくは1~4とされる。 Y is a hydrogen atom or an alkyl group. The number of carbon atoms in the alkyl group is preferably 1 to 12, and more preferably 1 to 4.
環Aが6員環である場合、R2~R6は、独立して、水素原子、水酸基、アミノ基、アルコキシ基、カルボキシル基またはカルボニル基である。また、環Aが5員環である場合、R2~R5は、独立して、水素原子、水酸基、アミノ基、アルコキシ基、カルボキシル基またはカルボニル基である。 When ring A is a 6-membered ring, R 2 to R 6 are independently a hydrogen atom, a hydroxyl group, an amino group, an alkoxy group, a carboxyl group, or a carbonyl group, and when ring A is a 5-membered ring, R 2 to R 5 are independently a hydrogen atom, a hydroxyl group, an amino group, an alkoxy group, a carboxyl group, or a carbonyl group.
なお、環Aが6員環である場合のR2~R6のいずれか、または、環Aが5員環である場合のR2~R5のいずれか、がカルボニル基である場合、環Aの環構成原子が炭素原子であり、かつ、その炭素原子と酸素原子との間が二重結合になっている構造を指して、カルボニル基という。 When ring A is a 6-membered ring and any of R 2 to R 6 is a carbonyl group, or when ring A is a 5-membered ring and any of R 2 to R 5 is a carbonyl group, the ring-constituting atom of ring A is a carbon atom and there is a double bond between the carbon atom and an oxygen atom, which is referred to as a carbonyl group.
環式化合物の具体例としては、例えば、安息香酸、フタル酸、イソフタル酸、テレフタル酸、ヘミメリット酸、トリメリット酸、トリメシン酸、メロファン酸、プレーニト酸、ピロメリット酸、フェニル酢酸、ヒドロキシフェニル酢酸、フェニル酪酸(フェニルラクテート)、ヒドロキシフェニル酪酸、フェニルピルビン酸、ヒドロキシフェニルピルビン酸、フェニル乳酸、ヒドロキシフェニル乳酸、アントラニル酸、ヒドロアトロパ酸、アトロパ酸、ヒドロケイ皮酸(クマル酸)、ケイ皮酸、サリチル酸(2-ヒドロキシ安息香酸)、m-サリチル酸(3-ヒドロキシ安息香酸)、p-サリチル酸(4-ヒドロキシ安息香酸)、メトキシ安息香酸、アミノ安息香酸、ヒドロキシ安息香酸、ピロカテク酸(2,3-ジヒドロキシ安息香酸)、β-レソルシル酸(2,4-ジヒドロキシ安息香酸)、ゲンチジン酸(2,5-ジヒドロキシ安息香酸)、γ-レソルシル酸(2,6-ジヒドロキシ安息香酸)、プロトカテク酸(3,4-ジヒドロキシ安息香酸)、α-レソルシル酸(3,5-ジヒドロキシ安息香酸)、トリヒドロキシ安息香酸、バニリン酸(4-ヒドロキシ-3-メトキシ安息香酸)、イソバニリン酸(3-ヒドロキシ-4-メトキシ安息香酸)、ベラトルム酸、没食子酸、シリング酸、アサロン酸、マンデル酸、バニルマンデル酸、アニス酸、ホモプロトカテク酸、ホモバニリン酸、ホモイソバニリン酸、ホモベラトルム酸、ホモフタル酸、ホモイソフタル酸、ホモテレフタル酸、フタロン酸、イソフタロン酸、テレフタロン酸、アトロラクチン酸、トロパ酸、メリロト酸、フロレト酸、ジヒドロカフェー酸、ヒドロフェルラ酸、ヒドロイソフェルラ酸、ウンベル酸、カフェー酸(コーヒー酸)、フェルラ酸、イソフェルラ酸、シナピン酸、シリンガ酸、デヒドロキナ酸、デヒドロシキミ酸、シキミ酸、コリスミ酸、L-トリプトファン、L-チロシン、プレフェン酸、アロゲン酸、L-フェニルアラニン等が挙げられる。 Specific examples of cyclic compounds include benzoic acid, phthalic acid, isophthalic acid, terephthalic acid, hemimellitic acid, trimellitic acid, trimesic acid, mellophanic acid, prenitic acid, pyromellitic acid, phenylacetic acid, hydroxyphenylacetic acid, phenylbutyric acid (phenyllactate), hydroxyphenylbutyric acid, phenylpyruvic acid, hydroxyphenylpyruvic acid, phenyllactic acid, hydroxyphenyllactic acid, anthranilic acid, hydroatropic acid, atropic acid, hydrophenyllactic acid, phenylacetate ... Cinnamic acid (coumaric acid), cinnamic acid, salicylic acid (2-hydroxybenzoic acid), m-salicylic acid (3-hydroxybenzoic acid), p-salicylic acid (4-hydroxybenzoic acid), methoxybenzoic acid, aminobenzoic acid, hydroxybenzoic acid, pyrocatechuic acid (2,3-dihydroxybenzoic acid), β-resorcylic acid (2,4-dihydroxybenzoic acid), gentisic acid (2,5-dihydroxybenzoic acid), γ-resorcylic acid (2,6-dihydroxybenzoic acid), protocatechuic acid (3,4-dihydroxybenzoic acid), α-resorcylic acid (3,5-dihydroxybenzoic acid), trihydroxybenzoic acid, vanillic acid (4-hydroxy-3-methoxybenzoic acid), isovanillic acid (3-hydroxy-4-methoxybenzoic acid), veratric acid, gallic acid, syringic acid, asaronic acid, mandelic acid, vanillylmandelic acid, anisic acid, homoprotocatechuic acid, homovanillic acid, homoisovanillic acid, homoveratric acid, homophthalic acid, homoisophthalic acid, homo These include terephthalic acid, phthalonic acid, isophthalonic acid, terephthalonic acid, atrolactic acid, tropic acid, mellitic acid, phloretic acid, dihydrocaffeic acid, hydroferulic acid, hydroisoferulic acid, umbellic acid, caffeic acid (caffeic acid), ferulic acid, isoferulic acid, sinapic acid, syringic acid, dehydroquinic acid, dehydroshikimic acid, shikimic acid, chorismic acid, L-tryptophan, L-tyrosine, prephenic acid, arogenic acid, and L-phenylalanine.
また、環式化合物の別の具体例としては、フラボノイド、リグナン、カルコン、スチルベノイド、アルカロイド、クルクミノイド、テルペノイド、サポニン、各種配糖体、各種ポリフェノール系芳香族化合物のようなポリフェノール類の他、アミノ酸、ビタミン等が挙げられる。 Other specific examples of cyclic compounds include polyphenols such as flavonoids, lignans, chalcones, stilbenoids, alkaloids, curcuminoids, terpenoids, saponins, various glycosides, and various polyphenol-based aromatic compounds, as well as amino acids and vitamins.
このうち、フラボノイドとしては、例えば、オーランチニジン、シアニジン、デルフィニジン、ヨーロピニジン、ルテオリニジン、ペラルゴニジン、マルビジン、ペオニジン、ペチュニジン、ロシニジンのようなアントシアニジン、プロシアニジンのようなアントシアニン、ナリンゲニン、エリオシトリン、ピノセムブリン、エリオジクチオールのようなフラバノン、カテキンのようなフラバン、アピゲニン、ルテオリン、バイカレイン、クリシンのようなフラボン、ケルセチン、ケンプフェロールのようなフラボノール、イソフラボン、イソフラバン、イソフラバンジオール、ゲニステインのようなイソフラボノイドの他、ネオフラボノイド、ビフラボノイド、オーロン、プレニル化フラボノイド、O-メチル化フラボノイド等が挙げられる。 Among these, examples of flavonoids include anthocyanidins such as aurantidin, cyanidin, delphinidin, europinidin, luteolinidin, pelargonidin, malvidin, peonidin, petunidin, and rosinidin, anthocyanins such as procyanidin, flavanones such as naringenin, eriocitrin, pinocembrin, and eriodictyol, flavans such as catechin, flavones such as apigenin, luteolin, baicalein, and chrysin, flavonols such as quercetin and kaempferol, isoflavones, isoflavones, isoflavanes, isoflavandiols, and isoflavonoids such as genistein, as well as neoflavonoids, biflavonoids, aurones, prenylated flavonoids, and O-methylated flavonoids.
また、リグナンとしては、例えば、ピノレシノール、ラリシレシノール、セコイソラリシレシノール、マタイレシノール、ヒドロキシマタイレシノール、シリンガレシノール、セサミン、アルクチゲニン、セサミノール、ポドフィロトキシン、ステガナシン等が挙げられる。 Examples of lignans include pinoresinol, lariciresinol, secoisolariciresinol, matairesinol, hydroxymatairesinol, syringaresinol, sesamin, arctigenin, sesaminol, podophyllotoxin, and steganacin.
さらに、スチルベノイドとしては、例えば、ピセアタンノール、ピノシルビン、プテロスチルベン、レスベラトロール、4’-メトキシレスベラトロール、ピノスチルベン、ピシアタノールのようなアグリコン、α-ビニフェリン、アンペロプシンA、アンペロプシンE、ジプトインドネシンC-カワン、ジプトインドネシンF-ダマールブア、ε-ビニフェリン、フレクスオソールA、グネチンH、ヘムスレヤノールD、ホペアフェノール、ジプトインドネシンB、バチカノールBのようなオリゴマー等が挙げられる。 Further examples of stilbenoids include aglycones such as piceatannol, pinosylvin, pterostilbene, resveratrol, 4'-methoxyresveratrol, pinostilbene, and piciatannol, and oligomers such as α-viniferin, ampelopsin A, ampelopsin E, diptoindonesin C-kawane, diptoindonesin F-dammarbua, ε-viniferin, flexosol A, gnetin H, hemsleyanol D, hopeaphenol, diptoindonesin B, and vaticanol B.
また、クルクミノイドとしては、例えば、クルクミン、ショウガオール等が挙げられる。 Curcuminoids include, for example, curcumin and shogaol.
さらに、テルペノイドとしては、例えば、ルテイン、ビタミンA、ビタミンE、βカロテンのようなカロテノイドの他、シトステロールのようなステロイド等が挙げられる。 Further examples of terpenoids include carotenoids such as lutein, vitamin A, vitamin E, and beta-carotene, as well as steroids such as sitosterol.
また、各種配糖体としては、例えば、サリシン、β-グルコガリン、サリチル酸グルコシド、サリドロシド、ガストロジン、ポプリン、フロリジン、アルブチンのようなフェノール配糖体、エスクリンのようなクマリン配糖体、ヘスペリジン、ルチンのようなフラボノイド配糖体、アストリンギン、ピセイド、ジプトインドネシンAのようなスチルベノイド配糖体等が挙げられる。 Examples of various glycosides include phenolic glycosides such as salicin, β-glucogallin, salicylic acid glucoside, salidroside, gastrodin, poplin, phloridzin, and arbutin, coumarin glycosides such as esculin, flavonoid glycosides such as hesperidin and rutin, and stilbenoid glycosides such as astringin, piceid, and diptoindonesin A.
さらに、各種ポリフェノール系芳香族化合物としては、例えば、チロソール、ヒドロキシチロソール、エスクレチン、フロレチン、ロスマリン酸、サルビアン酸A、レチクリン、パラクマリルアルコール、コニフェリルアルコール、カフェイルアルコール等が挙げられる。 Furthermore, various polyphenol-based aromatic compounds include, for example, tyrosol, hydroxytyrosol, esculetin, phloretin, rosmarinic acid, salvianic acid A, reticuline, paracoumaryl alcohol, coniferyl alcohol, caffeyl alcohol, etc.
また、アミノ酸としては、例えば、フェニルアラニン、チロシン等が挙げられる。
さらに、ビタミンとしては、例えば、ビタミンA、ビタミンD、ビタミンE等が挙げられる。
Furthermore, examples of amino acids include phenylalanine and tyrosine.
Furthermore, examples of vitamins include vitamin A, vitamin D, and vitamin E.
また、環式化合物のさらに別の具体例としては、芳香族化合物、脂環式化合物、脂肪族化合物、複素環式化合物等が挙げられる。 Further specific examples of cyclic compounds include aromatic compounds, alicyclic compounds, aliphatic compounds, and heterocyclic compounds.
このうち、芳香族化合物としては、例えば、バニリン、2-フェニルエタノール、フェニル酢酸、シンナミックアルコール、イソオイゲノール、フェルラ酸、4-アミノ安息香酸、アネトール、エストラゴール、アントラニル酸メチル、桂皮酸メチル、桂皮酸エチル、フェニルアセトアルデヒド、シンナミックアルデヒド、酢酸シンナミル、レゾルシン、4-ビニルフェノール、4-ビニル-2-メトキシフェノール、3,4-ジヒドロキシスチレン、ドーパミン、レボドパ、ハイドロキノン、クマリン、7-ヒドロキシクマリン、4-ヒドロキシクマリン、キシアメンマイシンA等が挙げられる。 Among these, examples of aromatic compounds include vanillin, 2-phenylethanol, phenylacetic acid, cinnamic alcohol, isoeugenol, ferulic acid, 4-aminobenzoic acid, anethole, estragole, methyl anthranilate, methyl cinnamate, ethyl cinnamate, phenylacetaldehyde, cinnamic aldehyde, cinnamyl acetate, resorcin, 4-vinylphenol, 4-vinyl-2-methoxyphenol, 3,4-dihydroxystyrene, dopamine, levodopa, hydroquinone, coumarin, 7-hydroxycoumarin, 4-hydroxycoumarin, and xiamenmycin A.
また、脂環式化合物としては、例えば、カルベオール、ペリラアルコール、ボルネオール、ジャスモン酸メチル、1,8-シネオール、L-メントン、バレンセン、ヌートカトン、α-ピネン、カンフェン、L-カルボン、ペリラアルデヒド、ミルテナール、酢酸L-メンチル、β-イオノン等が挙げられる。 Examples of alicyclic compounds include carveol, perilla alcohol, borneol, methyl jasmonate, 1,8-cineole, L-menthone, valencene, nootkatone, α-pinene, camphene, L-carvone, perilla aldehyde, myrtenal, L-menthyl acetate, and β-ionone.
さらに、脂肪族化合物としては、例えば、シス-3-ヘキセノール、酢酸シス-3-ヘキセニル、アセトイン、ネロール、ファルネソール、アルギニン、ムコン酸等が挙げられる。 Furthermore, examples of aliphatic compounds include cis-3-hexenol, cis-3-hexenyl acetate, acetoin, nerol, farnesol, arginine, muconic acid, etc.
また、複素環式化合物としては、例えば、ナイアシン、ナイアシンアミド、マルトール、インドール等が挙げられる。このうち、インドールとしては、例えば5,6-ジヒドロキシインドールが挙げられる。 Examples of heterocyclic compounds include niacin, niacinamide, maltol, and indole. Among these, an example of indole is 5,6-dihydroxyindole.
一方、環式化合物の誘導体としては、例えば、上述した化合物のエステル、酸無水物、アミド、酸ハロゲン化物、塩等、または、環式化合物から誘導される全ての化合物が挙げられる。 On the other hand, examples of derivatives of cyclic compounds include esters, acid anhydrides, amides, acid halides, salts, etc. of the above-mentioned compounds, or all compounds derived from cyclic compounds.
なお、環式化合物またはその誘導体の分子量は、特に限定されないが、120~1000であるのが好ましく、130~800であるのがより好ましい。 The molecular weight of the cyclic compound or its derivative is not particularly limited, but is preferably 120 to 1,000, and more preferably 130 to 800.
また、上記式(1)で表される環式化合物の環Aが、環構成原子が全て炭素原子である飽和環または部分飽和環の5員環である場合、R2~R5およびXが結合する環Aの炭素原子のうち、1つ以上が不斉炭素原子であるのが好ましい。また、上記式(1)で表される環式化合物の環Aが、環構成原子が全て炭素原子である飽和環または部分飽和環の6員環である場合、R2~R6およびXが結合する環Aの炭素原子のうち、1つ以上が不斉炭素原子であるのが好ましい。 When ring A of the cyclic compound represented by formula (1) is a five-membered saturated or partially saturated ring in which all of the ring-constituting atoms are carbon atoms, it is preferable that one or more of the carbon atoms of ring A to which R 2 to R 5 and X are bonded are asymmetric carbon atoms. When ring A of the cyclic compound represented by formula (1) is a six-membered saturated or partially saturated ring in which all of the ring-constituting atoms are carbon atoms, it is preferable that one or more of the carbon atoms of ring A to which R 2 to R 6 and X are bonded are asymmetric carbon atoms.
このような場合、環式化合物は立体異性体となる。この場合、本実施形態によれば、特定の立体異性体を高純度に含み、かつ、それ以外の立体異性体の含有率が低い環式化合物を高い収率で製造することが可能になる。その結果、不要な立体異性体の除去に伴う複雑な工程が必要なくなるので、製造コストの低コスト化を図ることができる。 In such a case, the cyclic compound becomes a stereoisomer. In this case, according to the present embodiment, it is possible to produce a cyclic compound with a high purity of a specific stereoisomer and a low content of other stereoisomers in a high yield. As a result, the complicated process of removing unnecessary stereoisomers is no longer necessary, and the production cost can be reduced.
また、上記式(1)で表される環式化合物においてXが結合する環Aの炭素原子をC1とし、R2が結合する環Aの炭素原子をC2とし、R3が結合する環Aの炭素原子をC3とし、R4が結合する環Aの炭素原子をC4とし、R5が結合する環Aの炭素原子をC5とし、R6が結合する環Aの炭素原子をC6としたとき、これらの炭素原子が不斉炭素原子である組み合わせが、下記(a)~(h)からなる群から選択される1種であることが好ましい。 In addition, in the cyclic compound represented by the above formula (1), when the carbon atom of ring A to which X is bonded is C1 , the carbon atom of ring A to which R2 is bonded is C2 , the carbon atom of ring A to which R3 is bonded is C3 , the carbon atom of ring A to which R4 is bonded is C4 , the carbon atom of ring A to which R5 is bonded is C5 , and the carbon atom of ring A to which R6 is bonded is C6 , it is preferable that the combination of these carbon atoms being asymmetric carbon atoms is one type selected from the group consisting of the following (a) to (h):
(a)C1
(b)C2
(c)C3
(d)C4
(e)C1およびC4
(f)C3およびC4
(g)C1、C3およびC4
(h)C3、C4およびC5
(a) C1
(b) C2
(c) C3
(d) C4
(e) C1 and C4
(f) C3 and C4
(g) C1 , C3 and C4
(h) C3 , C4 and C5
なお、下記式(2)は、上記式(1)で表される環式化合物に対し、上記C1~C6の表示を追記した式である。 The following formula (2) is a formula in which the above C 1 to C 6 indications are added to the cyclic compound represented by the above formula (1).
なお、環式化合物およびその誘導体は、上記式(2)で表される化合物であって、特に、3-デヒドロキネート、3-デヒドロシキミ酸、シキミ酸、コリスミ酸またはプレフェン酸であるのが好ましい。これらの化合物は、多くの分野で利用される化合物であって、その構造は以下の式で表される。 The cyclic compound and its derivatives are preferably compounds represented by the above formula (2), and more preferably 3-dehydroquinate, 3-dehydroshikimic acid, shikimic acid, chorismic acid, or prephenic acid. These compounds are used in many fields, and their structures are represented by the following formula:
・3-デヒドロキネート 3-dehydroquinate
・3-デヒドロシキミ酸 ・3-dehydroshikimic acid
・シキミ酸 ・Shikimic acid
・コリスミ酸 - Chorismic acid
・プレフェン酸 - Prephenic acid
以上のような環式化合物またはその誘導体の用途としては、特に限定されないが、例えば、香料組成物、化粧料組成物、医薬品、農薬、化学薬品、電気・電子部品用材料、合成繊維、樹脂、食品添加物等の各種化成品が挙げられる。また、環式化合物またはその誘導体は、各種化成品の原料としても用いられる。この原料としては、例えば、香料原料、化粧料原料、医薬品原料、農薬原料、化学薬品原料、電気・電子部品用原料、合成繊維原料、樹脂原料、食品添加物原料等が挙げられる。なお、原料とは、化成品の合成に用いられる中間体のことをいう。 The uses of the above-mentioned cyclic compounds or their derivatives are not particularly limited, but examples of such uses include various chemical products such as fragrance compositions, cosmetic compositions, pharmaceuticals, pesticides, chemicals, materials for electrical and electronic parts, synthetic fibers, resins, and food additives. Cyclic compounds or their derivatives are also used as raw materials for various chemical products. Examples of such raw materials include raw materials for fragrances, cosmetic materials, pharmaceutical materials, pesticide raw materials, chemical raw materials, raw materials for electrical and electronic parts, raw materials for synthetic fibers, raw materials for resins, and raw materials for food additives. Note that raw materials refer to intermediates used in the synthesis of chemical products.
以上、本発明の環式化合物またはその誘導体の製造方法を実施形態に基づいて説明したが、本発明はこれらに限定されるものではない。 The above describes the method for producing the cyclic compound or its derivative of the present invention based on the embodiments, but the present invention is not limited to these.
例えば、本発明の環式化合物またはその誘導体の製造方法は、前記実施形態に任意の工程が付加されたものであってもよい。 For example, the method for producing a cyclic compound or a derivative thereof of the present invention may include any step added to the above embodiment.
次に、本発明の具体的実施例について説明する。
1.環式化合物の製造
(実施例1)
[1]まず、バイオマスに前処理を施し、混合糖を得た。
Next, specific examples of the present invention will be described.
1. Preparation of cyclic compounds (Example 1)
[1] First, biomass was pretreated to obtain a sugar mixture.
[2]次に、増殖させた形質転換体を、混合糖と反応させ、培養液を得た。得られた培養液を遠心分離し、上清液(原料液体)を得た。 [2] Next, the grown transformant was reacted with a sugar mixture to obtain a culture solution. The culture solution was centrifuged to obtain a supernatant (raw liquid).
[3]次に、得られた原料液体に酢酸を添加した。
[4]次に、得られた原料液体を噴霧乾燥法(スプレードライ法)により乾燥させ、粒子状の乾燥物を得た。なお、加熱温度は、温風の入口温度を120℃、出口温度を80℃とした。また、原料液体の供給量は、0.64kg/hとした。
[3] Next, acetic acid was added to the obtained raw material liquid.
[4] Next, the obtained raw material liquid was dried by a spray drying method to obtain a particulate dried product. The heating temperature was set to 120° C. at the inlet and 80° C. at the outlet of the hot air. The supply rate of the raw material liquid was set to 0.64 kg/h.
[5]次に、得られた乾燥物からメタノールを用いて環式化合物を固液抽出した。これにより、抽出液を得た。なお、固液抽出処理の温度は30℃、時間は2時間、溶媒の量は乾燥物1gに対して20gとした。 [5] Next, the cyclic compounds were extracted from the dried product using methanol. This resulted in an extract. The temperature of the solid-liquid extraction process was 30°C, the time was 2 hours, and the amount of solvent was 20 g per 1 g of dried product.
[6]次に、得られた抽出液を加熱して濃縮し、含まれる溶媒を蒸発させた。これにより、固体のシキミ酸(環式化合物)を析出させ、回収した。 [6] Next, the obtained extract was heated and concentrated to evaporate the solvent contained therein. This caused the solid shikimic acid (cyclic compound) to precipitate and be recovered.
[7]次に、回収した固体のシキミ酸を純水に再溶解させた。なお、再溶解に使用した純水の量は、固体のシキミ酸1gに対して5gとした。 [7] Next, the recovered solid shikimic acid was redissolved in pure water. The amount of pure water used for redissolution was 5 g per 1 g of solid shikimic acid.
[8]次に、得られた再溶解液に活性炭を添加し、活性炭処理を施した。なお、活性炭は、再溶解液100gに対して0.4g使用した。 [8] Next, activated carbon was added to the redissolved solution obtained, and activated carbon treatment was performed. Note that 0.4 g of activated carbon was used per 100 g of the redissolved solution.
[9]次に、活性炭処理を施した再溶解液に貧溶媒としてエタノールを添加した。これにより、固体のシキミ酸(環式化合物)を析出させた。その後、析出物をろ過により固液分離し、エタノールを用いて洗浄後、析出物を乾燥させ、回収した。 [9] Next, ethanol was added as a poor solvent to the redissolved solution that had been treated with activated carbon. This caused solid shikimic acid (a cyclic compound) to precipitate. The precipitate was then separated into solid and liquid by filtration, washed with ethanol, and then dried and collected.
(実施例2~14)
製造条件を表1に示すように変更した以外は、実施例1と同様にしてシキミ酸(環式化合物)を得た。
(Examples 2 to 14)
Shikimic acid (cyclic compound) was obtained in the same manner as in Example 1, except that the production conditions were changed as shown in Table 1.
なお、表1の実施例8における「濃縮晶析」とは、濃縮処理と、冷却晶析処理と、を順次行って固体のシキミ酸を析出させる処理のことである。
また、真空乾燥法における密閉容器内の圧力は、1Paとした。
In addition, "concentration and crystallization" in Example 8 of Table 1 refers to a process in which a concentration process and a cooling and crystallization process are sequentially performed to precipitate solid shikimic acid.
The pressure inside the closed container was set to 1 Pa in the vacuum drying method.
(実施例15)
[1]まず、バイオマスに前処理を施し、混合糖を得た。
[2]次に、増殖させた形質転換体を、混合糖と反応させ、培養液を得た。得られた培養液を遠心分離し、上清液(原料液体)を得た。
(Example 15)
[1] First, biomass was pretreated to obtain a sugar mixture.
[2] Next, the grown transformant was reacted with a sugar mixture to obtain a culture solution, which was then centrifuged to obtain a supernatant (raw liquid).
[3]次に、得られた原料液体に酢酸を添加した。
[4]次に、得られた原料液体を噴霧乾燥法(スプレードライ法)により乾燥させ、粒子状の乾燥物を得た。
[3] Next, acetic acid was added to the obtained raw material liquid.
[4] Next, the obtained raw material liquid was dried by a spray drying method to obtain a particulate dried product.
[5]次に、乾燥物を純水に再溶解させた。なお、再溶解に使用した純水の量は、乾燥物1gに対して5gとした。 [5] Next, the dried material was redissolved in pure water. The amount of pure water used for redissolution was 5 g per 1 g of dried material.
[6]次に、得られた再溶解液に活性炭を添加し、活性炭処理を施した。なお、活性炭は、再溶解液100gに対して0.4g使用した。 [6] Next, activated carbon was added to the redissolved solution obtained, and activated carbon treatment was performed. Note that 0.4 g of activated carbon was used per 100 g of the redissolved solution.
[7]次に、有機溶媒として1-ブタノールを用い、再溶解液に対して液液抽出処理を施した。これにより、1-ブタノールを溶媒とする溶液を得た。
[8]次に、濃縮乾固により、溶質を析出させ、析出物を回収した。
[7] Next, the redissolved liquid was subjected to liquid-liquid extraction treatment using 1-butanol as an organic solvent, thereby obtaining a solution containing 1-butanol as a solvent.
[8] Next, the solute was precipitated by concentration to dryness, and the precipitate was collected.
(実施例16~18)
製造条件を表2に示すように変更した以外は、実施例15と同様にしてシキミ酸(環式化合物)を得た。
(Examples 16 to 18)
Shikimic acid (cyclic compound) was obtained in the same manner as in Example 15, except that the production conditions were changed as shown in Table 2.
(実施例19)
[1]まず、実施例15と同様にして再溶解液に活性炭処理を施した。
[2]次に、再溶解液を再び噴霧乾燥させ、粒子状の乾燥物を得た。なお、加熱温度は、温風の入口温度を120℃、出口温度を80℃とした。また、原料液体の供給量は、0.64kg/hとした。
(Example 19)
[1] First, the redissolved solution was treated with activated carbon in the same manner as in Example 15.
[2] Next, the redissolved liquid was spray-dried again to obtain a particulate dried product. The heating temperature was set to 120° C. at the inlet and 80° C. at the outlet of the hot air. The supply rate of the raw material liquid was set to 0.64 kg/h.
[3]次に、得られた乾燥物からメタノールを用いて環式化合物を固液抽出した。これにより、抽出液を得た。なお、固液抽出処理の温度は30℃、時間は2時間、溶媒の量は乾燥物1gに対して20gとした。 [3] Next, the cyclic compounds were extracted from the dried product using methanol. This resulted in an extract. The temperature of the solid-liquid extraction process was 30°C, the time was 2 hours, and the amount of solvent was 20 g per 1 g of dried product.
[4]次に、得られた抽出液を加熱して濃縮し、含まれる溶媒を蒸発させた。これにより、固体のシキミ酸(環式化合物)を析出させ、回収した。 [4] Next, the obtained extract was heated and concentrated to evaporate the solvent contained therein. This caused the solid shikimic acid (cyclic compound) to precipitate and be recovered.
(実施例20~22)
製造条件を表2に示すように変更した以外は、実施例19と同様にしてシキミ酸(環式化合物)を得た。
(Examples 20 to 22)
Shikimic acid (cyclic compound) was obtained in the same manner as in Example 19, except that the production conditions were changed as shown in Table 2.
(比較例)
[1]まず、バイオマスから微生物発酵によりメタンを製造した。
Comparative Example
[1] First, methane was produced from biomass through microbial fermentation.
[2]次に、メタンを原料とし、ゼオライトにモリブデンおよび鉄を担持した触媒による反応を経て、ベンゼンを製造した。その後、蒸留によりベンゼンを精製した。
[3]次に、ベンゼンからシキミ酸を合成した。
[2] Next, methane was used as a raw material and reacted with a catalyst made of zeolite carrying molybdenum and iron to produce benzene, which was then purified by distillation.
[3] Next, shikimic acid was synthesized from benzene.
(参考例)
市販されているシキミ酸の試薬を用意した。
(Reference example)
A commercially available shikimic acid reagent was prepared.
2.環式化合物の評価
2.1 純度の測定
各実施例および比較例で得られた環式化合物について、高速液体クロマトグラフィー(HPLC)により、シキミ酸の純度を測定した。なお、純度は、回収した固体の全質量に対するシキミ酸の質量の割合(単位:質量%)とした。
また、測定条件は、以下の通りである。
2. Evaluation of cyclic compounds 2.1 Purity measurement The purity of shikimic acid in the cyclic compounds obtained in each Example and Comparative Example was measured by high performance liquid chromatography (HPLC). The purity was expressed as the ratio of the mass of shikimic acid to the total mass of the recovered solid (unit: mass%).
The measurement conditions are as follows.
<シキミ酸のHPLC分析条件>
カラム:COSMOSIL 5C18-AR-II(φ4.6mm×250mm)ナカライテスク社製
移動相:水/メタノール/過塩素酸=4/1/0.0075(vol/vol/vol)イソクラティック溶出
流量:1mL/min
カラム温度:40℃
検出方法:フォトダイオードアレイ(PDA)検出器(210nm)
測定結果を表1、2に示す。
<HPLC analysis conditions for shikimic acid>
Column: COSMOSIL 5C18-AR-II (φ4.6 mm × 250 mm) manufactured by Nacalai Tesque Mobile phase: water/methanol/perchloric acid = 4/1/0.0075 (vol/vol/vol) isocratic elution Flow rate: 1 mL/min
Column temperature: 40°C
Detection method: Photodiode array (PDA) detector (210 nm)
The measurement results are shown in Tables 1 and 2.
2.2 収率の評価
各実施例および比較例で得られた環式化合物について、高速液体クロマトグラフィー(HPLC)と質量測定により、シキミ酸の収率を測定した。なお、収率は、原料液体中のシキミ酸の量を高速液体クロマトグラフィー(HPLC)により算出し、回収した固体の質量とシキミ酸の純度から回収量を算出し、原料液体中のシキミ酸の量に対する回収したシキミ酸の割合(単位:%)とした。
測定結果を表1、2に示す。
2.2 Yield Evaluation The yield of shikimic acid was measured for the cyclic compounds obtained in each Example and Comparative Example by high performance liquid chromatography (HPLC) and mass measurement. The yield was calculated by calculating the amount of shikimic acid in the raw liquid by high performance liquid chromatography (HPLC), calculating the recovered amount from the mass of the recovered solid and the purity of shikimic acid, and expressing it as the ratio (unit: %) of the recovered shikimic acid to the amount of shikimic acid in the raw liquid.
The measurement results are shown in Tables 1 and 2.
2.3 白色度の評価
各実施例および比較例で得られた環式化合物ならびに参考例の市販試薬について、分光色彩白度計により、ISO白色度を測定した。
測定結果を表1、2に示す。
2.3 Evaluation of Whiteness The ISO whiteness of the cyclic compounds obtained in the Examples and Comparative Examples and the commercially available reagent of the Reference Example was measured using a spectrophotometer.
The measurement results are shown in Tables 1 and 2.
表1、2から明らかなように、各実施例では、高い純度の環式化合物を高い収率で回収することができた。 As is clear from Tables 1 and 2, in each example, it was possible to recover high purity cyclic compounds in high yields.
なお、シキミ酸に代えて、環式化合物の一例である4-ヒドロキシ安息香酸の製造(回収)も行ったところ、表1、2に示す結果と同様の傾向が認められた。 In addition, we also produced (recovered) 4-hydroxybenzoic acid, an example of a cyclic compound, instead of shikimic acid, and observed similar trends to the results shown in Tables 1 and 2.
S01 原料液体調製工程
S02 酸性化工程
S03 乾燥工程
S04 抽出工程
S05 析出工程
S06 再溶解工程
S07 吸着工程
S01 Raw material liquid preparation step S02 Acidification step S03 Drying step S04 Extraction step S05 Precipitation step S06 Re-dissolving step S07 Adsorption step
Claims (7)
前記原料液体に乾燥剤を入れた後、前記原料液体を減圧下に置いて真空乾燥させることにより、前記原料液体の濃縮を進行させる乾燥工程と、
前記原料液体に抽出用溶媒を入れてシキミ酸またはその誘導体を抽出し、抽出液を得る抽出工程と、
前記抽出液の溶質を固体として得る析出工程と、
前記析出工程の後に設けられ、前記溶質を良溶媒に溶解させる再溶解処理を施し、溶液を得る工程と、
前記溶液に活性炭処理を施す工程と、
前記活性炭処理が施された前記溶液に対し、貧溶媒を添加する再沈殿処理を施し、沈殿を固体として回収する工程と、
を有し、
前記原料液体に対し、前記乾燥剤および前記抽出用溶媒を添加することにより、前記乾燥工程および前記抽出工程を同時に行い、
回収された前記固体は、粉末状をなしており、JIS P 8148:2001に規定されたISO白色度の試験方法に準じて測定されたISO白色度が70%以上であることを特徴とするシキミ酸またはその誘導体の製造方法。 A raw material liquid preparation step of preparing a raw material liquid containing shikimic acid or a derivative thereof from biomass;
a drying step of adding a desiccant to the raw liquid and then vacuum-drying the raw liquid under reduced pressure to concentrate the raw liquid;
An extraction step of adding an extraction solvent to the raw material liquid to extract shikimic acid or a derivative thereof to obtain an extract;
a precipitation step of obtaining the solute of the extract as a solid;
a step of performing a re-dissolving process after the precipitation step, in which the solute is dissolved in a good solvent to obtain a solution;
subjecting the solution to an activated carbon treatment;
a step of subjecting the solution that has been treated with activated carbon to a reprecipitation treatment by adding a poor solvent and recovering a precipitate as a solid;
having
The drying step and the extraction step are carried out simultaneously by adding the desiccant and the extraction solvent to the raw material liquid;
A method for producing shikimic acid or a derivative thereof, characterized in that the recovered solid is in powder form and has an ISO whiteness of 70% or more as measured in accordance with the ISO whiteness test method specified in JIS P 8148:2001.
前記乾燥剤の添加量は、前記濃縮液100gに対して1~300gである請求項1に記載のシキミ酸またはその誘導体の製造方法。 The drying step includes a process of adding the desiccant to a concentrated liquid obtained by concentrating the raw material liquid, and further concentrating the concentrated liquid,
2. The method for producing shikimic acid or a derivative thereof according to claim 1, wherein the amount of the desiccant added is 1 to 300 g per 100 g of the concentrated liquid .
前記原料液体を真空乾燥させ、乾燥物を得る乾燥工程と、
前記乾燥物を良溶媒に溶解させる再溶解処理を施し、溶液を得る再溶解工程と、
前記溶液に活性炭処理を施す吸着工程と、
抽出用溶媒により、前記活性炭処理を施した前記溶液からシキミ酸またはその誘導体を液液抽出し、抽出液を得る抽出工程と、
前記抽出液の溶質を固体として回収する析出工程と、
を有し、
回収された前記固体は、粉末状をなしており、JIS P 8148:2001に規定されたISO白色度の試験方法に準じて測定されたISO白色度が70%以上であることを特徴とするシキミ酸またはその誘導体の製造方法。 A raw material liquid preparation step of preparing a raw material liquid containing shikimic acid or a derivative thereof from biomass;
a drying step of vacuum drying the raw material liquid to obtain a dried product;
a redissolving step of dissolving the dried product in a good solvent to obtain a solution;
an adsorption step of subjecting the solution to an activated carbon treatment;
an extraction step of liquid-liquid extracting shikimic acid or a derivative thereof from the solution treated with the activated carbon using an extraction solvent to obtain an extract;
a precipitation step of recovering the solute from the extract as a solid;
having
A method for producing shikimic acid or a derivative thereof, characterized in that the recovered solid is in powder form and has an ISO whiteness of 70% or more as measured in accordance with the ISO whiteness test method specified in JIS P 8148:2001.
前記溶液に活性炭処理を施す工程と、
前記活性炭処理が施された前記溶液に対し、貧溶媒を添加する再沈殿処理を施し、沈殿を固体として回収する工程と、
を有する請求項3に記載のシキミ酸またはその誘導体の製造方法。 a step of performing a re-dissolving process after the precipitation step, in which the solute is dissolved in a good solvent to obtain a solution;
subjecting the solution to an activated carbon treatment;
a step of subjecting the solution that has been treated with activated carbon to a reprecipitation treatment by adding a poor solvent and recovering a precipitate as a solid;
The method for producing shikimic acid or a derivative thereof according to claim 3 , comprising the steps of:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019159036A JP7476499B2 (en) | 2019-08-30 | 2019-08-30 | Method for producing shikimic acid or its derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019159036A JP7476499B2 (en) | 2019-08-30 | 2019-08-30 | Method for producing shikimic acid or its derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021038157A JP2021038157A (en) | 2021-03-11 |
JP7476499B2 true JP7476499B2 (en) | 2024-05-01 |
Family
ID=74848176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019159036A Active JP7476499B2 (en) | 2019-08-30 | 2019-08-30 | Method for producing shikimic acid or its derivatives |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7476499B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021193565A1 (en) * | 2020-03-27 | 2021-09-30 | 住友ベークライト株式会社 | Production method for cyclic compound or derivative thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002006203A1 (en) | 2000-07-14 | 2002-01-24 | Dsm N.V. | Process for the recovery of shikimic acid |
US20070149805A1 (en) | 2005-12-23 | 2007-06-28 | Stephen F. Austin State University | Method for the extraction and purification of shikimic acid |
US20130137895A1 (en) | 2010-03-12 | 2013-05-30 | Council Of Scientific & Industrial Research | Method for the extraction of shikimic acid |
CN107652178A (en) | 2017-10-30 | 2018-02-02 | 广西万山香料有限责任公司 | The method that shikimic acid is extracted from anise |
WO2019044773A1 (en) | 2017-08-30 | 2019-03-07 | 住友ベークライト株式会社 | Functional skin preparation for external use, antimicrobial agent and method for producing aromatic polyhydroxycarboxylic acid or derivative thereof |
-
2019
- 2019-08-30 JP JP2019159036A patent/JP7476499B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002006203A1 (en) | 2000-07-14 | 2002-01-24 | Dsm N.V. | Process for the recovery of shikimic acid |
US20070149805A1 (en) | 2005-12-23 | 2007-06-28 | Stephen F. Austin State University | Method for the extraction and purification of shikimic acid |
US20130137895A1 (en) | 2010-03-12 | 2013-05-30 | Council Of Scientific & Industrial Research | Method for the extraction of shikimic acid |
WO2019044773A1 (en) | 2017-08-30 | 2019-03-07 | 住友ベークライト株式会社 | Functional skin preparation for external use, antimicrobial agent and method for producing aromatic polyhydroxycarboxylic acid or derivative thereof |
CN107652178A (en) | 2017-10-30 | 2018-02-02 | 广西万山香料有限责任公司 | The method that shikimic acid is extracted from anise |
Also Published As
Publication number | Publication date |
---|---|
JP2021038157A (en) | 2021-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Alam et al. | Choline chloride-based deep eutectic solvents as green extractants for the isolation of phenolic compounds from biomass | |
Huang et al. | Ionic deep eutectic solvents for the extraction and separation of natural products | |
Zhou et al. | Enhanced phenolic compounds extraction from Morus alba L. leaves by deep eutectic solvents combined with ultrasonic-assisted extraction | |
Jiang et al. | Extraction, purification and applications of curcumin from plant materials-A comprehensive review | |
Saha et al. | Effect of choline chloride-oxalic acid based deep eutectic solvent on the ultrasonic assisted extraction of polyphenols from Aegle marmelos | |
Setyaningsih et al. | Stability of 40 phenolic compounds during ultrasound-assisted extractions (UAE) | |
Yang et al. | Efficient extraction of bioactive flavonoids from Ginkgo biloba leaves using deep eutectic solvent/water mixture as green media | |
Fujimori et al. | Enhanced solubility of quercetin by forming composite particles with transglycosylated materials | |
JP7476499B2 (en) | Method for producing shikimic acid or its derivatives | |
CN113677783A (en) | Water soluble additive composition | |
Cai et al. | A green and designable natural deep eutectic solvent-based supramolecular solvents system: Efficient extraction and enrichment for phytochemicals | |
WO2021009374A1 (en) | Ionic liquid-type compounds and their methods of preparation and uses | |
Guo et al. | Effective extraction and recovery of linarin from Chrysanthemum indicum L. flower using deep eutectic solvents | |
Mohite et al. | Synthesis of fisetin co-crystals with caffeine and nicotinamide using the cooling crystallization technique: biopharmaceutical studies | |
Salehi et al. | Micronization and coating of bioflavonoids extracted from Citrus sinensis L. peels to preparation of sustained release pellets using supercritical technique | |
Zu et al. | Purification of Ginkgo biloba extract by antisolvent recrystallization | |
JP6052183B2 (en) | Gel of reduced pyrroloquinoline quinone | |
JP7476498B2 (en) | Method for producing 4-hydroxybenzoic acid or its derivatives and method for producing chemical products | |
Li et al. | Ultrasonic assisted extraction of anthocyanins from rose flower petal in DES system and enzymatic acylation | |
Percevault et al. | Extraction of plant and algal polyphenols using eutectic solvents | |
Spyros et al. | Structure determination of oligomeric alkannin and shikonin derivatives | |
WO2021193565A1 (en) | Production method for cyclic compound or derivative thereof | |
Solaimalai et al. | Exploring the novel green eutectic solvent for the synthesis of 4-hydroxy-2-methyl-N-2-pyridinyl-2 H-1, 2,-benzothiazine-3-carboxamide 1, 1-dioxide with benzoic acid cocrystal using a co-grinding technique | |
JP2009149596A (en) | New method for quickly extracting useful component in indigo leaf | |
JP5255862B2 (en) | Antidiabetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220704 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230710 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230725 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230922 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231121 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240119 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240319 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240401 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7476499 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |